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ABSTACT OF THE DISSERTATION
CHARACTERIZATION OF AN EPOXIDE HYDROLASE FROM THE FLORIDA
RED TIDE DINOFLAGELLATE, KARENIA BREVIS
by
Pengfei Sun
Florida International University, 2015
Miami, Florida
Professor Kathleen S. Rein, Major Professor
Polyether compounds are a subgroup of natural products with regular occurrence
of multiple C-O-C motifs. The biosynthetic origin of polycylic polethers has been studied
and the majority of them are derived from polyketide or terpene pathways. Normally, the
polycyclic polyethers can be divided into two groups based on their structural features:
the first group features multiple rings that are interconnected by carbon-carbon single
bond, which are produced by a biosynthetic cascade of exo epoxide-opening reactions;
the other group has multiple fused cyclic ethers and are formed by an cascade of endo
epoxide-opening reactions.
Karenia brevis (K. brevis) is known as principle harmful bloom (HAB) organism
of the Gulf of Mexico which can cause red tides. Brevetoxins (PbTx) are a suit of cyclic
polyether ladder compounds produced by K. brevis. Brevetoxins are neurotoxins that can
bind to voltage-gated sodium channels in nerve and muscle cells, resulting in disruption
of normal neurological processes causing the human illness which is clinically described
as neurotoxic shellfish poisoning (NSP).

v

Inspired by Cane-Celmer-Wesley’s proposal regarding monensin biosynthesis,
Nakanishi and Shimizu proposed a biosynthetic pathway for brevetoxin which suggests
that PKS-mediated synthesis of the polyene is followed by epoxidation to afford a
polyepoxide which then undergoes an epoxide-opening cascade, catalyzed by an epoxide
hydrolase (EH).
To find evidence to support the hypothesis that an epoxide hydrolase from
polyether ladder producing dinoflagellates will catalyze the construction of the polyether
ladder framework from polyepoxide substrates, and to study the role of epoxide
hydrolase in the biosynthesis of polyether ladder compounds, it is necessary to identify
and produce one or more epoxide hydrolase from dinoflagellates. The methods to detect
epoxide hydrolase activity in K. brevis and different techniques to obtain epoxide
hydrolases from K. brevis are discussed. A microsomal EH identified from a K. brevis
EST library was cloned and expressed. The characterization of this EH, including
substrate selectivity and enantioselectivity as well as its potential to catalyze the critical
ento-tet cyclization epoxy alcohol, is discussed.
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1. BACKGROUND
1.1 DINOFLAGELLATE
Dinoflagellates are members of the class Dinophyceae, which is a diverse group of
unicellular, flagellate algae that fossil records suggested have been in existence for at
least 400 million years 1. Dinoflagellates are one of the three main phyla of the protozoan
taxon Alveolata. The other two are the parasitic apicomplexans and the mostly free-living
ciliates. Motile dinoflagellate cells have two flagella, one longitudinal and one transverse
which encircles the cell, and this design causes a corkscrew-like swimming motion from
which the name dinoflagellate is derived (Greek dinos = whirling). Their unique
propulsion system has been studied over the last several decades 2. In terms of number of
species, dinoflagellates are one of the largest groups of marine eukaryotes 3. However,
the dinoflagellate nuclei are not characteristically eukaryotic, as they lack histones,
nucleosomes and maintain continually condensed chromosomes during mitosis. However,
they do contain typically eukaryotic organelles, such as mitochondria, chloroplasts, and
Golgi

bodies

4

.

Figure

1

shows

one

dinoflagellate

(http://www.sms.si.edu/irlspec/Phyl_Dinofl.htm).

Figure 1. Dinoflagellate Gonyaulax sp.

1

Gonyaulax

sp.

Most dinoflagellates are marine plankton, but more than 200 species are found in
fresh water 5. Their growth is affected by temperature, salinity or depth. Although many
dinoflagellates are photosynthetic, a large fraction of these are in fact mixotrophic,
combining photosynthesis with ingestion of prey 6. Some species are endosymbionts of
marine animals and play an important role in the biology of coral reefs, for instance
Symbiodinium, the coral symbiont 7. Other dinoflagellates are predators on other
protozoa, and some forms are parasitic. They are also known to produce novel secondary
metabolites including heterocycles, macrolides, highly oxygenated alkyl compounds
among others 8. The chloroplasts of photosynthetic dinoflagellates have been studied for
the evolution of organelle genomes. The most common type of dinoflagellate chloroplast
is bound by 3-membranes and contain chlorophylls a and c2, the carotenoid beta-carotene
and xanthophylls that seems to be unique to dinoflagellates, mainly peridinin,
dinoxanthin and diadinoxanthin. Many dinoflagellates show goldenbrown color because
of these pigments. However, Karenia brevis, Karenia mikimotoi and Karlodinium
micrum, have other pigments through endosymbiosis, including fucoxanthin 9. Most
dinoflagellates have a haplontic life cycle. The reproduction type is binary fission, either
desmoschisis or eleuteroschisis

10

. In a small percentage of dinoflagellates, sexual

reproduction also occurs 11.
Dinoflagellates can bloom in a very high concentration resulting in red tides. The
toxins, known as dinotoxins produced by dinoflagellates can kill fish and accumulate in
filter feeders such as shellfish, which may be passed on to people who eat them.
However, some dinoflagellate blooms are not hazardous. Bioluminescent dinoflagellate

2

can emit short flashes of light when disturbed. There are more than 28 dinoflagellates
which are bioluminescent and most of them emit a blue-green light

12

. These species

contain dinoflagellate luciferase, the main enzyme in dinoflagellate bioluminescence and
luciferin, a chlorophyll derived tetrapyrrole ring which acts as the substrate in the
luminescent reaction 13.
The large amount of DNA of dinoflagellate is one of their most striking features.
Dinoflagellate DNA can range from 3 ~ 250 pg/cell, whereas most other eukaryotic algae
contain on average 0.54 pg/cell

14

. In addition, dinoflagellate nuclei are unique in their

morphology, composition and regulation.

1.2 KARENIA BREVIS (K. BREVIS)
Karenia, formerly included in the genus Gymnodinium, is a genus of 12 species of
dinoflagellates

15

. Several species can cause red tides, including K. brevis, and Karenia

mikimotoi, which was first described in Japan, but is now found in the Atlantic ocean 16.
These species are similar in their pigmentation and possession of a linear apical groove,
but can be distinguished by morphological characteristics and large subunit (LSU) rRNA
gene sequences 17.
Karenia brevis (genus Karenia species brevis, formerly known as Gymnodinium
breve and Ptychodiscus brevis) is an unarmored, photosynthetic marine dinoflagellate. It
is a microscopic, single-celled organism that is responsible for frequent blooms along
Florida and Texas coastal waters. K. brevis uses its two flagella to move through the
water in a spinning motion. Karenia brevis cell is about 20-40 μm in size, the cell color is
yellow-green because of the presence of chloroplasts

3

18

. Karenia brevis has a 1011 bp

genome, which is approximately 30 times the human genome. It has permanently
condensed chromatin lacking nucleosomes. The condensed chromosomes have a
characteristic banding pattern with stacked disks which form a continuous left-handed
twist along the longitudinal axis. Due to its huge size, the genome has not yet been
sequenced

19

.

Karenia

was

brevis

shown

in

Figure

2

(https://upload.wikimedia.org/wikipedia/commons/a/a0/Karenia_brevis.jpg).

Figure 2. Karenia brevis

Karenia brevis can be found in the Gulf of Mexico, along the coasts of Texas,
Louisiana, Florida, and North Carolina. It is photosynthetic and performs much of the
area's primary production, which is the synthesis of organic compounds from
atmospheric or aqueous carbon dioxide
light

20

18

. Normally, K. brevis moves towards greater

and against gravity 21, which results in keeping the cells at the surface of water.

Because of dependence on light, they cannot live at a depth below 200 feet. The optimal
temperature for their growth is between 22-28°C, although they can survive in a
temperature range between 4 and 33 °C. In addition, K. brevis requires salinity between
25-45 ppt. They can provide oxygen to the environment contributing around 20 % of the
primary production in the West Florida Shelf during blooms or red tides 22.

4

Multiple reasons may lead to a chemical change in water. The most common is
when chemicals are dumped into the water from local run-off zones. These chemicals can
come from certain fertilizers which are used to promote agricultural growth. The algae
will reproduce rapidly if nutrient levels such as nitrogen increase beyond normal levels,
resulting in an algal bloom. These blooms can deplete oxygen in the water and create a
shade from the sun, inhibiting the growth of other autotrophs

23

. Karenia brevis can

produce harmful algal blooms (HABs) or red tides, during which toxins are released in
the ocean and may kill marine animals, and cause human illness that can arise from
eating seafood that have retained toxins. Blooms of K. brevis may also provide a
significant source of fixed carbon thorough photosynthesis 24. With nutrient regimes and
light conditions, K. brevis can bloom from 100,000 to 250,000 cells/liter within 2 months
25

. Monospecific blooms can cover a surface area of up to 1.4-3.0 × 104 km2

24

. An

historical assessment of K. brevis in the western Gulf of Mexico found documented
reports of massive fish kills together with human respiratory irritation and dry cough
from Veracruz, Mexico in the late 1800s, and earlier evidence of red tides on the
Mexican coastline dating back to the 1500s

26

. Throughout most of the Gulf of Mexico

and US south Atlantic Bight, K. brevis is found in background concentration levels of 11000 cells/liter

25

. Blooms are most frequent along the west coast of Florida, especially

from Clearwater to Sanibel Island. Most commonly, blooms can last more than two
months in regions of the Gulf of Mexico including: the west Florida shelf, the Campeche
Bay between Rio Ciatzacoalcos and Rio Grijalva, and the Texas coast between Port
Arthur and Galveston Bay 25.

5

Karenia brevis has attracted great interest among scientists. Microscopy or
pigment analysis are among the traditional methods for the detection of K. brevis.
However, those methods are time-consuming and require an experienced microscopist for
identification 27. Molecular and PCR based methods for detection of K. brevis cells have
been developed 28. Another technique, which uses a model-based examination of UV-vis
spectra, multiwavelength spectroscopy has also been used for detection of K. brevis 29.

1.3 BREVETOXINS
Brevetoxins (PbTx) are a suit of cyclic polyether ladder compounds. Brevetoxins
are neurotoxins that can bind to voltage-gated sodium channels in nerve and muscle cells,
resulting in disruption of normal neurological processes causing the human illness which
is clinically described as neurotoxic shellfish poisoning (NSP)

30

. Brevetoxins have two

main skeletal types, brevetoxin A and brevetoxin B, which differ in the carbon backbone.
Each type of brevetoxin has several subtypes, which differ in the side-chain substituents
31

.

Figure 3. Different types of brevetoxins

6

Brevetoxins are lipid soluble and adversely affect human health as well as
ecosystems. Brevetoxins are most studied in K. brevis, but they are also found in other
species of Karenia

30

. The toxins activate voltage-gated sodium channels in vertebrates

directly damaging the nervous system of an organism even at very small concentrations.
This results in neurological symptoms in the affected organism, including humans. The
most common way for humans to be exposed to these toxins is through the consumption
of contaminated shellfish. Ecological health effects include massive mortality of
invertebrates, fish, birds, and some marine mammals. This could be due to either direct
exposure to the toxins or from the brevetoxins in the food web

32

. Due to its extensive

adverse impacts on coastal environments and communities, the growth physiology and
toxicity of K. brevis have been studied for over 60 years. Research on the underlying
molecular biology has not been initiated until the last decade, which is enabled by the
availability of rapidly evolving molecular technologies from the biomedical field 19. The
processes contributing to the development of K. brevis blooms span spatial and temporal
scales from the molecular mechanisms within the cell that respond the environmental
cues to the oceanographic and even atmospheric processes that drive the local
environmental conditions in which K. brevis lives. How a bloom is initiated and
terminated remains poorly understood, but is crucial for the prediction and management
of bloom impacts. However, the integration of the cellular responses with these physical
forcings is needed to refine these models. A lack of information on these processes
severely limits predictive models as they require a more thorough understanding of the
cellular level decisions through which K. brevis interacts with its environment 19.

7

1.4 POLYETHER COMPOUNDS
Polyether compounds are a subgroup of natural products with regular occurrence
of multiple C-O-C motifs. Polyethers are commonly divided into two categories, linear
and polycylic. The latter group is especially interesting because of the structural diversity
and biological activities, which include antibiotic, antifungal, and anticancer. The origin
of polycylic polethers has been studied and the majority of them are derived from
polyketide, such as brevetoxins (Figure 3, above), or terpene pathways such as entAbudinol B

33

and terurilene 34. Normally, the polycyclic polyethers can be divided into

two groups based on their structural features: the first group features multiple rings that
are interconnected by carbon-carbon single bond, and it’s produced by an biosynthetic
cascade of exo epoxide-opening reactions; the other group has multiple fused cyclic
ethers and are formed by an cascade of endo epoxide opening 35.

Figure 4. Terpene derived polyethers (left: terurilene; right: ent-Abudinol B)

1.4.1 Ladder polyethers
Ladder polyethers are one type of polyether with ladder-like configuration. The
ladder polyethers contain 4 to 32 five- to nine- member fused rings. The first isolated
polyether ladder compound is brevetoxin B. Numerous others have been found including
maitotoxin, the largest nonpolymer isolated from natural source 36. Ladder polyethers are

8

known to be associated with harmful algal blooms, commonly referred to as red tide. Due
to the uniform structures, ladder polyethers show various biological activities ranging
from extreme toxicity to beneficial anticancer and antifungal character

37

. Many ladder

polyethers and their analogs were found to have the potential to improve human health.
For example, brevenal, which is also a secondary metabolite of K. brevis, has the
potential of treatment of the debilitating lung disorder cystic fibrosis (CF) by effective
clearance of mucus from the lungs 38. Cystic fibrosis afflicts 30,000 people in the United
States. It has been demonstrated that brevenal is one million times more effective than
amiloride in enhancing mucus clearance from lungs. However, the supply of this
dinoflagellate-derived substance is very limited, which has prevented full exploration of
its therapeutic value. Figure 5 shows two ladder polyethers: brevenal and yessotoxin.

Figure 5. Ladder polyethers (top: brevenal; bottom: yessotoxin)

9

Normally, there are three ways to obtain the natural products: extraction and
purification from the producing organism, total synthesis or genetically engineering
biosynthetic pathways in a heterologous host. The first source for obtaining the PE ladder
is also not practical due to its low yield. Several milligram of brevetoxins may be
obtained from several hundred liters of K. brevis culture. The total synthesis of many
natural products, the other source, is quite challenging and time-consuming. The
chemical synthesis of the PE ladder motif is still extremely challenging, though total
syntheses of these complex molecules has been accomplished. In 1995, after 12 years of
effort, the Nicoloau group completed the first total synthesis of a PE ladder, brevetoxin B
39

. Brevetoxin A was first synthesized in 1998 also by Nicoloau group, in 34 steps

40

.

Another synthesis of brevenal, a relatively simple polyether ladder, was described as
highly efficient, but still the longest linear sequence required no less than 32 synthetic
steps

41

. These compounds were synthesized several times subsequent to the first

synthesis 41b, 42. However, due to the structural complexity, all syntheses required over 30
steps and total yields were less than 5% even when the average yield in each individual
step reached up to 90%.
Several biomimetic syntheses of PE ladders via epoxides have been reported. The
epoxide ring opening can proceed via both favored, but undesired exo-tet cyclization and
the disfavored, but desired endo-tet cyclization. Therefore, strategies to direct the
cyclization have been introduced into the syntheses by incorporating directing groups to
favor the endo-tet cyclization or to disfavor the exo-tet

43

. More recently, the Jamison

group utilized a polyxpoxide cascade to construct more than three rings in only one step;
water was used to overcome the inherent exo-tet selectivity. But this method needs

10

templating of the substrate with a pyran ring. Furthermore, the reaction is slow, the yields
are poor, and side products were produced.

Figure 6. a) cyclization modes and directing strategies b) Jamison's polyepoxide cascade

1.4.2 Baldwin’s rules
As mentioned above, one of the biggest challenges challenging for the synthesis
of PE ladder compounds through the biomimetic routes is that the endo-tet cyclization is
disfavored. Baldwin’s rule, first proposed by Jack Baldwin in 1976, provides a set of
guidelines ranking the relative favorability of ring closure in alicyclic compounds

44

.

Relative rates of ring closure of these types of compounds were discussed. These rules
are not meant to describe the absolute probability that a reaction will or will not take
place; rather they are used in a relative sense. A disfavored reaction does not have a rate
that can compete effectively with the other reaction that is favored. However, the
disfavored product may still be observed

44

. Figure 7 (below) showed a ring closure

reaction in the top, and favor or disfavor of the ring closure in the bottom.

11

Figure 7. Baldwin'rules (top: ring closure reactions; bottom: dis/favored ring closure)

1.4.3 Polyether ionophores
Besides ladder polyethers, polyether ionophores are another large group of
polyethers. They are lipophilic carboxylic acids containing multiple five- and sixmembered cyclic ethers, either as spiroketals or as linked bicyclic ethers. Nigericin and
lasalocid are the first members isolated in this family 45. Not until an X-ray structure of
monesin A was disclosed

46

and cation binding abilities of these molecules were first

examined 47, did this family of polyethers start drawing great attention. Over one hundred
members in this family have been isolated and characterized, most of which are produced
by bacteria of the the genus Streptomyces. Their ability to control coccodiosis, a
devastating poultry disease, and promote growth of ruminant, inspired numbers of
scientists to isolate novel ionophore polyethers, make efforts on their total synthesis and
study their biosynthesis. Polyether ionophores can exhibit numerous biological effects
including antibiotic, anti-obesity and insecticide activity, by disturbing the delicate
dynamic equilibrium of cations across the cell membrane
ionophore polyethers tetronomycin and cationmycin.

12

48

. Figure 8 shows two

Figure 8. Ionophore polyethers (left: tetronomycin; right: cationomycin)

1.5 POLYKETIDE BIOSYNTHESIS
Brevetoxins are members of the polyketide family of natural products.
Polyketides are mostly produced by bacterial, filamentous fungi, plants and algae.
Polyketides exhibit high structural diversity and vary widely in pharmacological effects,
but they share a common biosynthetic origin

49

. All polyketides carbon backbone

construction is catalyzed by polyketide synthase (PKS) through a pathway which is
highly similar to fatty acid biosynthesis. In the polyketide biosynthetic pathway, small
units derived from acetate, propionate or butyrate, are condensed into a carbon chain by a
PKS. PKSs have been identified as type I (non-iterative), type II (iterative), and type III
(chalcone synthase).
Type I PKSs are large multifunctional enzymes that are organized into modules,
each of which directs one cycle of chain extension and condensation. Typically, one PKS
module should contain the ketosynthase domain (KS) that elongates the chain, the acyl
carrier protein (ACP) that provides a thiol binding site where intermediates are added,
and the acyl transferase domain (AT) that transfers units from acyl-CoA precursors to the
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ACP.
A
Addittional domaiins may exiist to modify
fy a β-keto including thhe keto-reduuctase
(K
KR), dehydrratase (DH), and enoyl reductase
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(ER). More reecent studiess have shownn that
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n some typee I PKS mo
odules which
h lack AT domains, thhe corresponnding functiion is
caarried out by
y an iterativee AT enzymee 50.

Figure 9. Type I PKS (Shen, 2003))

Type II PKS, carrrying a singlle set of iteraatively actinng activities, are multienzyme
co
omplexes. Four
F
of the domains
d
in ty
ype II PKS, KS, AT, K
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of known typ
pe I PKSs, however,
h
thee fifth domaain, residingg at the C-teerminus (term
minal
domain, TD), is unique to
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KSs. Type II PKS whichh lack ACP, utilize acyl CoA
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h C-C and C-O bond form
mation in thhe biosynthessis.

Figure 10.. Type II PKS
S (Shen, 20033)

Type III PKSs, kn
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g enzymes. Their structture are disttinct from Type I
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Figure 11. Type III PKS
S (Shen, 20033)
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der pathway has yet to be revealedd. The prevaailing
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p forth neearly 30 yeaars ago by N
Nakanishi, suggests thaat PKS-meddiated
sy
ynthesis of the
t polyene is followed by epoxidaation to afforrd a polyepooxide whichh then
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ndergoes an
n epoxide-op
pening casccade, catalyzzed by an epoxide hydrolase (EH
H), to
prrovide the polyether
p

51

. This hypoth
hesis, whichh remains unnconfirmed, accounts foor the

ox
xygen-carbo
on-carbon (O
O–C–C) con
nnectivity ppattern and ttrans-syn toopography inn the
natural produ
ucts and is su
upported by the recent iddentificationn of moleculaar oxygen (O
O2) as
he source off the ether oxygen
o
atom
ms in the strructurally siimilar PE laadder yessottoxin,
th
prroduced by the
t dinoflageellate Protocceratium retticulatum 52.
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1.6.1 Biosynthesis of ionophore polyethers
1.6.1.1 Cane-Celmer-Wesley model (1983)
The fact that the universal building blocks of the polyether carbon skeleton are
acetate, propionate and butyrate was well recognized by the early 1980s. Studies on the
orgins of the oxygens in monensin were then carried by Cane and Wesley. They fed
Streptomyces cinnamonensis, monensin-producing bacterium, with
carboxylic acid precursors

53

or in molecular oxygen

54
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O either in

. Their studies revealed that that

not all oxygens are derived from the corresponding subunits like acetate, propionate, and
butyrate, but also from molecular oxygen. The groups of Cane, Celmer and Wesley then
proposed a unified stereochemical model of polyether structure and biogenesis in 1983 55.
According to their model for the biosynthesis of monensin A, an all-E polyene precursor
is first produced from five acetates, seven propionates and one butyrate in a type I PKS
manner. Then the polyene is oxidized to the corresponding polyepoxide by oxygen. One
hydroxyl group attacks the ketone forming a hemiketal, triggering a cascade of epoxideopening and ring closure leading to the formation of monensin
extended to the biosynthesis of all known polyether ionophores.

16

55

. This model was then

Figure 12. proposed pathway of biosynthesis of monensin

1.6.1.2 Townsend-Basak model (1991)
Numerous

polyether

molecules

followed

Cane-Celmer-Wesley

proposal.

However, despite significant efforts to do so, the all-E premonensin, the proposed
precursor of monensin was never found. Townsend and Basak then proposed an alternate
biosynthetic pathway 56. In this model, instead of an all-E precursor, it was proposed that
monensin may be produced from an all-Z polyene precursor through several oxidative
cyclizations involving the action of an iron-containing monooxygenase. This proposal

17

was supported by synthetic studies

57

and the work on model systems related to all-Z

premonensin by McDonald 58.

Figure 13. Townsend-Basak model

1.6.1.3 Leadlay model (2001)
Another precursor of monensin was proposed by Leadlay in 2001
proposal, a Z,Z,E-polyene is required en route to monensin

59

59

. In his

. The biosynthetic gene

cluster was sequenced in their group. This is the first polyether gene cluster identified.
They found that this polyketide gene cluster contains twelve modules, which are
responsible for the incorporation of twelve acyl units of monensin. From the gene cluster,
the genes monBI, monBII and monCI were identified 60. The products of both monBI and
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monBII were thought to act as isomerases, supporting their modification of the CaneCelmer-Wesley model. Deletion of monCI may lead to accumulation of all-E
premonensin polyene 61, indicating that the product of monCI, a single oxidase enzyme, is
required in the production of polyepoxide. MonCII showed significant sequence and
structural similarity to the EH. However, latter they found that the active site nucleophile
in MonCII enzyme is a serine, different from the conserved aspartate residue. They then
reassigned monCII as a thioesterase responsible for releasing the product in monensin
biosynthesis. Disruption of monBI and monBII genes, which were latter proved to be
EHs, resulted in the production of partially cyclized intermediates

62

, suggesting the

epoxide opening and ring closure are catalyzed by the MonB enzymes, rather than by the
enzyme MonCII as previous thought.

1.6.1.4 Biosynthesis of lasalocid
More direct evidence of the involvement of an enzyme-catalyzed cascade of
epoxide-opening reactions in the biosynthesis of polyether was provided by Oikawa in
their study of lasalocid biosynthesis

63

. They analyzed biosynthetic genes of lasalocid,

reavealing high homology of lsd19 to the putative EH genes monBI and monBII. They
obtained pure Lsd19 enzyme by cloning and expressing the lsd19 gene in E. coli. A series
of enzymatic reactions were carried out by incubating the enzyme and prelasalocid
diepoxides in vitro

64

. The efficient transformation of a proposed substrate

bisepoxyprelasalocid and its synthesized analogue suggested Lsd19 is indeed an EH.
Leadlay’s in vivo studies on the production of lasalocid in the producing organism and a
mutant lacking lsd19 clearly demonstrated that Lsd19 changes the regioselectivity of
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polyether ring formation. They found when Lsd19 is not present, the formation of the
second ring proceeds the kinetically favored pathway to form isolasalocid, instead of
lasalocid

65

. Latter studies on Lsd19 revealed it is composed two subunits, Lsd19A

responsible for furan ring formation, and Lsd19B, taking roles in pyran ring formation,
which are linked by a short loop and are oriented in a head-to-tail fashion.

Figure 14. Comparison of with or without Lsd19 (left: lasalocid; right: isolasalocid)
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1.6.2 Biosynthesis of ladder polyethers
Shortly after the structure of brevetoxin B, the first ladder polyether reported, was
determined in the 1980’s, efforts to understand the biosynthesis of these complex
molecules began. Stable isotope incorporation experiments using

13

C-labelled acetate

revealed the polyketide origins of the brevetoxins, yet some anomalies in the labeling
patterns, were also observed

51b, 66

. In the feeding experiment, of the 50 carbons of

brevetoxin B, 16 carbons showed enrichment from [1-13C] acetate, 30 carbons from [213

C] acetate, and 4 carbons from methyl-methionine. The origins of the carbon atoms in

the brevetoxins have been determined, the remainder of the polyether ladder pathway has
yet to be revealed. Inspired by the Cane-Celmer-Wesley proposal on monensin
biosynthesis, Nakanishi and Shimizu proposed a biosynthetic pathway for brevetoxin
which suggests that PKS-mediated synthesis of the polyene is followed by epoxidation to
afford a polyepoxide which then undergoes an epoxide-opening cascade, catalyzed by an
EH, to provide the polyether (Figure 15)

51

. They believed that the structural and

stereochemical similarity among brevetoxins are a direct consequence of their
biosynthetic origin. A single oxidase could be sufficient, as all alkenes in the hypothetical
polyene precursor would require identical stereoselectivity of epoxidation to produce
wither an all-S, S or all-R, R polyepoxide. As described above, according to Baldwin’s
rules

44, 62

, epoxide ring opening reactions favors THF rather than THP, suggesting that

the cascades should have to overcome ten separate disfavored epoxide opening reactions.
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Figure 15. Proposed biosynthetic pathway of brevetoxin

Although the origins of the carbon atoms in the brevetoxins are confirmed, the
subsequent epoxidation and cyclizations are still unrevealed. Labeling experiments with
18

O2 revealed that the oxygens in the fused THP diad of okadaic acid are derived from

molecular oxygen 67, suggesting that an epoxide intermediate is involved in the formation
of this ladder polyether like motif, which provided support for the proposal.
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Figure 16. Structure of Okadaic acid

Giner and Mullins proposed that the ladder polyethers are derived from all-Z
polyene precursor 68. In their proposal, an epoxy ester intermediate undergos cyclization
with the carbonyl as nucleophile, resulting in the formation of an orthoester. Upon the
collapse of orthoester, the hydroxyl group attacks the previous electrophilic site of the
starting cis epoxide, produces the ring in the ladder and generates an ester for next
cyclization reaction. However, this proposal has not been tested.

Figure 17. Biosynthesis of ladder polyethers in epoxy ester pathway

Recent identification of molecular oxygen (O2) as the source of the ether oxygen
atoms in the structurally similar PE ladder yessotoxin, produced by the dinoflagellate
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Protoceratium reticulatum

52

provides significant support for Nakanishi’s proposal. This

study examined the results of feeding experiment using 18O with either molecular oxygen
or [18O2] acetate. The analysis of these experiments revealed that the ether oxygens are
derived from 18O2, and the hydroxyl oxygen is from [18O2] acetate. These results suggest
that a polyene precursor is oxidized by a monooxygenase after acetate condensation,
which supports Cane-Celmer-Wesley model, as well as Nakanishi and Shimizu’s
hypothesis. In addition, it was suggested the direction of epoxide ring formation was
from tail to head (right to left) and a monooxygenase formed predominantly an all (S, S)polyepoxide intermediate from an E-polyene intermediate.

Figure 18. Origins of oxygen in yessotoxin

1.7 EPOXIDE HYDROLASE (EH, E.C.3.3.2.3)
Epoxide-containing compounds are very widely found in the environment, and a
large variety of aromatic and alkenic compounds are also metabolized to epoxides
endogenously 69. An epoxide (also known as oxirane), a three-membered cyclic ether, has
specific reactivity patterns owing to the highly polarized oxygen-carbon bonds in
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addition to a highly strained ring

70

. Most epoxides are moderately reactive, relatively

stable at physiological pH, and do not present acute dangers to cells, but they still need to
be transformed in a controlled manner. EHs can catalyze epoxide hydrolysis to yield the
corresponding 1,2-diol, which is only one of several ways that cells transform epoxides 71.

1.7.1 Function of EHs
In different organisms, the role of EHs differs greatly. Generally, EHs have three
functions: detoxification, catabolism, and regulation of signal molecules. In
microorganisms, EHs are important in the catabolism of specific carbon sources from
natural sources, like tartaric acid or limonene 72. However, studies on microbial EHs are
mainly for their potential use as chiral catalysts for enzymatic syntheses 73. In plants, EHs
seem important in cuticle formation, responses to stress, and pathogen defense

74

. In

several insects, EHs have also been characterized, where the role of the enzyme is
mediating developmental chemical, juvenile hormone, and detoxification of many plant
chemical defenses. In mammals, there are also many EHs, including soluble EH (sEH),
microsomal EH (mEH), and cholesterol EH (chEH), which hydrolyze the 5,6-oxide of
cholesterol and other epoxy steroids. In the past 30 years, sEH and mEH have been
mostly studied. Although these enzymes were first distinguished by their subcellular
localization, they also have distinct and complementary substrate specificity

75

. These

two enzymes are very concentrated in liver, but they are found in nearly all tissues. They
are thought to complement each other in detoxifying a wide range of mutagenic, toxic
and carcinogenic xenobiotic epoxides. However, recent studies found the mEH is
involved in xenobiotic metabolism and the onset of several diseases
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76

, and the sEH is

involved in the regulation of blood pressure and inflammation

77

. What’s interesting is

that inhibition of the sEH seems to be a potential therapeutic treatment for several
diseases, including high blood pressure, atherosclerosis, and kidney failure.
Understanding of EHs mechanism of action is a prerequisite for development of potent
inhibitors. Although the mechanism has been studied since the enzymes were discovered,
major breakthroughs were made in the past 20 years because of the availability of
recombinant EHs 69.

1.7.2 Different types of EHs
Three types of EH, which operate through distinct catalytic mechanisms, have
been identified

69

. The most studied of these belong to the larger family of hydrolases

containing an α, β-fold and are often referred to as α, β-hydrolases. All sEH and mEH in
mammals belong to this category. A second type of EH is the leukotriene-A4 (LTA4)
hydrolase

78

. The LTA4 hydrolase is highly substrate specific, converting LTA4 into

leukotriene-B4 (LTB4). Only two other substrates, the double bond isomers LTA3 and
LTA5, have been identified. The third EH is the limonene-1, 2-epoxide hydrolase (LEH),
which was first identified to hydrolyze limonene 1-2-epoxide to limonene-1,2-diol
(Figure 19) and recognized as a new type of EH in 1998 79.

Figure 19. LEH hydrolysis
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1.7.2.1 α, β-fold EH
Most EHs belong to the α, β-hydrolase fold superfamily of proteins. The α,βhydrolase fold is widely found in hydrolytic enzymes of differing phylogenetic origin and
catalytic function. The core of the enzyme in this family is an α,β-sheet, containing 8 βsheets connected by 6 α-helices

80

. The enzymes have a catalytic triad, the elements of

which are borne on loops, which are very conserved structural features of the fold.
However, the catalytic domains of the enzymes do not share obvious sequence similarity,
nor do they operate on similar substrates. Nevertheless, they are believed to evolve from
a common ancestor due to their structural similarity and preservation of the arrangement
of the catalytic residues 81. Beside EH, this superfamily also includes proteases, lipases,
peroxidases, esterases, and dehalogenases.
All known α, β-fold epoxide EHs are characterized by a nucleophile-histidineacid catalytic triad. The mechanism is two-step involving the formation of a covalent
intermediate

82

. Before the two-step mechanism was described, the generally accepted

mechanism was a general-base-catalyzed direct attack of water on the epoxide ring. The
triad of these enzymes can be described as nucleophile-histidine-acid. Two conserved
tyrosine residues and a conserved Asp-His-Asp catalytic triad make up the active site.
The tyrosines are believed to serve as general acids for activation of the epoxide by
forming two hydrogen bonds with the oxygen 83. The carboxylate group of one of the Asp
residues is activated by the His and other Asp in the active site and is the nucleophile that
attacks the epoxide, typically at the least substituted carbon. In a second step a water
molecule, activated by the His-Asp charge relay, cleaves the ester that is formed,
liberating the diol and regenerating the enzyme as shown in Figure 20.
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Figure 20. Mechanism of α, β-fold EH

1.7.2.2 Leukotriene-A4 (LTA4) hydrolase
Leukotrienes, first discovered in leukocytes, are a class of lipid mediators
involved in inflammatory and allergic reactions. 5-Lipoxygenase converts arachidonic
acid into epoxide intermediate LTA4, which is then hydrolyzed into the proinflammatory
lipid mediator leukotriene B4 (LTB4) by LTA4 hydrolase. LTA4 hydrolase (EC 3.3.2.6) is
a bifunctional zinc metalloenzyme, besides EH activity, it also exhibits an anion
dependent aminopeptidase activity. It is commonly believed that peptidase activity is
involved in the bioactive peptides related to inflammation 78.
The LTA4 hydrolase is highly substrate specific, converting LTA4 into
leukotriene-B4 (LTB4). Only two other substrates, the double bond isomers leukotriene A3
(LTA3) and leukotriene A3 (LTA5), have been identified.

28

Figure 21. Substrates of leukotriene A4 hydrolase

In this enzyme's active site two histidines and a glutamate coordinate a Zn2+ ion, which in
turn coordinates the epoxide oxygen. Upon activation of the 5, 6-epoxide, an intermediate
carbocation, whose charge is delocalized over a conjugated triene system, is quenched at
C-12 by a water molecule which is activated and delivered by a conserved Asp residue, to
produce a 5, 12-diol rather than a 1, 2-diol. The active site has two domains with
structures very different from those of α,β-hydrolase. A covalent adduct between the
enzyme and substrate is not formed in this process making it distinct from the α,βhydrolase type.
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Figure 22. Mechanism of leukotriene A4 hydrolase

1.7.2.3 Limonene EH
Limonene EH (LEH) was first found to be involved in the limonene degradation
pathway in Rhodococcus erythropolis, in which it allows the bacterium to grow on
limonene as carbon source. LEHs do not exhibit any sequence similarity to the α,βhydrolases. LEH can hydrolyze limonene-1,2-epoxide to produce limonene-1,2-diol. In
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both structure and mechanism, LEHs are different from α,β-hydrolase fold EHs.
Structurally, LEH is much smaller, and does not contain any highly conserved motifs of
the catalytic triads found in α,β-hydrolase fold EHs and exhibits a novel active site
structure in the LEH crystal structure

84

. LEH contains a curved β-sheet with three α-

helices on top. Five charged residues constitute the active site.
In LEH, the epoxide is activated by hydrogen bonds to an Asp residue. However,
as in the case of LTA4 hydrolase, a water molecule is activated and delivered by Asn, Asp
and Tyr residues in a one-step mechanism and a covalent intermediate is not formed 84.
Figure 23 shows the mechanism of LEH.

Figure 23. Mechanism of LEH

All EHs which are confirmed to be involved in the biosynthesis of non-ladder
type polyethers are of the LEH type. Genes coding for LEHs have been identified in the
biosynthetic gene clusters for the bacterial polyethers monenesin
nanchangmycin
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, tetronomycin
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and nigericin

87

60

, lasalocid

. In the case of monensin

62, 88

65

,

and

lasalocid 63, 89, these EHs encoding genes have been expressed and the EH activity of the
enzymes confirmed.
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2. SEARCH FOR EHS
2.1 INTRODUCTION
As described previously, EHs are believed to be able to cyclize polyepoxides into
polyethers

55

. EHs from Karenia brevis were proposed to catalyze a kinetically

disfavored endo-tet cyclization to produce brevetoxins from polyene precursors. There
are three types of EHs: α,β-fold EHs, limonene EHs, and leukotriene-A4-hydrolase. Most
known EHs belong to α,β-fold class of EHs.

Objectives
•

Find evidence to support the hypothesis that EH from polyether ladder producing
dinoflagellates will catalyze the construction of the polyether ladder framework
from polyepoxide substrates

•

Study the role of EH in the biosynthesis of polyether ladder compounds, and

•

Evaluate the potential of EH in semi-enzyme synthesis.

To achieve these objectives, it is necessary to identify and produce one or more
EH from dinoflagellates. In this chapter, different methods were described to search for
various classes of EHs in K. brevis.
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2.2 RESULTS AND DISCUSSION
2.2.1 Screening cell free extracts (CFE)
2.2.1.1 EH detection in Karenia brevis
Prior to attempting to obtain an EH from K. brevis, it is crucial to prove that
EH(s) exist in the organism. Detection of EH activity from K. brevis utilized a sensitive
fluorescent assay as shown below in Figure 24. The substrate 2 was prepared from transtyrylacetic acid and 7-methoxy-2-napthaldehyde 90.
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Figure 24. Synthesis of fluorescent probe 1

Typically, an EH will catalyze epoxide ring opening to yield the corresponding
1,2-diol. An EH catalyzed hydrolysis of the epoxide substrate, compound 2 produces an
intermediate diol which lactonizes to release the fluorescent reporter 3 after hydrolysis of
the intermediate cyanohydrin as shown in Figure 25.
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Figure 25. EH activity detection strategy

Cell free extracts (CFE) of K. brevis were prepared and evaluated for EH activity.
The protein concentration of K. brevis CFE was adjusted to 0.25 ~0.5 mg/mL based on
the Bradford protein assay. Gluocose-6-phosphate dehydrogenase activity was evaluated
to insure the CFE has retained sufficient enzymatic activity. The concentration of
fluorescent reporter was calculated for each reading according to a standard curve of the
reporter.

The result (Figure 26) showed that the K. brevis cell free extracts have

significant EH activity.
EH activity in K. brevis CFE

Reporter 3 concentration
(uM)

5
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4
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3
2
1
0
0
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400
Time (min)

Figure 26. EH activity in K. brevis CFE
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2.2.1.2 Detection of esterase activity
Esterase, which hydrolyzes an ester into a carboxylic acid and an alcohol, can also
catalyze the hydrolysis of the fluorescent probe 2 and produce the fluorescent report 3
(Figure 27).

Figure 27. Esterase catalyzed hydrolysis yields the same fluorescent reporter as EH

To confirm the activity observed in the K. brevis CFE is due to EH activity not esterase
activity, the precursor of the fluorescent probe 1 without the epoxide group was used as
the substrate in the assay. An observation of significant difference (~2 fold in rate of
formation of fluorescent reporter 3) in EH activity vs esterase activity suggested the K.
brevis CFE did have EH activity, and that the difference between total activity using the
EH probe and esterase activity reflected EH activity alone.
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Esterase activity in K. brevis CFE
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Figure 28. EH and esterase activity in K. brevis CFE

2.2.1.3 Assays with EH inhibitors
The EH activity of K. brevis CFE was examined in the presence of known
inhibitors of two of the three classes of EH: adamantly urea 4, inhibitor of mouse (Ki of
0.33 μM) and human (Ki of 6.2 μM) α,β-hydrolase type

91

and two inhibitors of the

Rhodococcus erythropolis LEH: hexylamine 5 (Ki of 35 μM) and valpromide 6 (Ki of
100 μM) as shown in Figure 29 84. Due to the substrate specificity and unique mechanism
of the LTA4 hydrolase, it is unlikely that our probe would detect such activity.

Figure 29. Structure of EH inhibitors

The inhibitor of α,β-hydrolase type EH, adamantyl urea 4 was synthesized from
N-(1-adamantyl) urea 90, as shown in Figure 30 .
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Figure 31. EH activity in K. brevis cultures and sensitivity to inhibitors (top: EH activity in K.
brevis CFE in the presence of adamantyl urea; bottom: EH activity in K. brevis CFE in the
presence of valpromide and hexylamine)

To insure the inhibition observed in the EH assay with adamantyl urea was a result of the
inhibition of EH rather than esterase, and the sensitivity of the esterase assay to
adamantly urea was examined using the alkene 1. No inhibition of esterase activity was
observed under same condition (Figure 32).
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Figure 32. Esterase activity in K. brevis cultures and sensitivity to inhibitors

Among the three EH inhibitors, only adamantly urea 4 inhibited the total activity
in the K. brevis CFE (Figure 31 top) when using the fluorescent probe 2 as the substrate.
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These data suggested that the observed EH activity in K. brevis CFE can be attributed, at
least in part, to an EHs of the α,β-hydrolase type.

2.2.2 EH from cDNA library
After detection of EH activity and inhibition with the known EH inhibitor
adamantyl urea 4, efforts were made to identify EHs in K. brevis. A K. brevis cDNA
library served as a resource to search for EHs.

2.2.2.1 Screening from high salt condition
An EH cDNA was isolated from the plant Solanum commersonii cDNA library by
plating the cDNA library under high salt conditions (0.8M NaCl) 92. Of the 106 bacterial
cells plated, only thirteen colonies grew, yielding seven genes related to stress response
including a soluble EH. The authors speculated that the EH was able to hydrolyze
reactive epoxides produced during oxidative stress induced oxidative burst. The same
strategy was used for searching EHs from a K. brevis cDNA library.
A cDNA library from K. brevis poly (A)+ RNA was constructed in a λ ZAP
Express vector

93

. The phagemid was excised and host cells, E. coli strain, SOLR were

infected. The cDNA library was plated on high salt plates (2YT agar with 50 ug/mL
ampicillin, 1mM isopropyl-β-D-thiogalactoside (IPTG) and 0.8 M NaCl). One hundred
sixty-six colonies (~ 2/3 of what grew) were picked and streaked on the same media.
Seventy-eight out of 166 grew and were inoculated into LB broth. The plasmids were
extracted (Qiagen) and sent to Eurofins Genomics for sequencing using T3 primer.
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tBLASTx analysis was performed for all the sequences returned from Eurofins
Genomics against the non-redundant protein database of NCBI. Some showed very high
homology to known genes, such as that of the chloroplast light harvesting protein.
However, many sequences did not share significant similarity with any known genes.
Table 1 showed all the sequences with an E value lower than 1e-4 to some known
sequence. Of forty-six sequence with an E value lower than 1e-4 to NCBI database, eight
sequences showed homology to complete genome of some organisms, which lead to
failure to identify the gene. For those assigned sequences, unfortunately, no EH-like
genes were obtained. The survival strategies in high salt conditions for those recombinant
cells are not known, but it’s very interesting to find these genes are of high salt stress
tolerance.
Table 1. High salt screening results

Accession No. of most similar known
Predicated protein

E-value
sequence

Unknown

XM_002291564.1

9e-08

Histone-like protein

AF482694.1

6e-24

Light harvesting protein

EF134091.1

3e-88

AB461927.1

7e-131

PAP fibrillin family protein

XM_002293371.1

9e-30

RNA binding protein

EF134110.1

3e-5

n-acetylglucosamine-6-

XM_001568585.1

3e-38

Methionine S-adenosyl
transferase
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phosphate deacetylase
Oxidase-like protein

XM_002683903.1

9e-22

Unknown

CP001964.1

5e-4

XM_001315691.1

5e-36

TRP superfamily protein

XM_001637522.1

1e-10

Unknown (basic nuclear protein)

EF134106.1

1e-15

Plectin-like protein

XM_002611742.1

3e-14

XM_690776.2

1e-3

Unknown

XM_001737438.1

2e-22

Amidase

CP000828.1

8e-158

Unknown

GU554554.1

9e-12

Light harvesting protein

DQ118623.1

6e-140

Light harvesting protein

DQ118619.1

6e-122

TPR Domain containing protein

XM_001640397.1

2e-127

Non-transporter ABC protein

XM_003080218.1

3e-44

XM_002293751.1

2e-32

Kenesin

XM_002677784.1

4e-23

Light harvesting protein

DQ118623.1

4e-129

S-adenosylmethionine synthetase

DQ865292.1

1e-43

Carbamoyltransferase family
protein

Calcium/calmodulin-dependent
protein kinase

Phosphoadenosinephosphosulphate reductase
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Unknown

GU554554.1

4e-13

SET domain-containing protein

XM_002952571.1

5e-13

Chloride channel protein

XM_002772754.1

2e-6

Ribosomal RNA protein

DQ779991.1

2e-131

phosphoglycerate mutase

XM_002677423.1

3e-30

CRE-GRSP-2 protein

CP000251.1

2e-6

Unknown

XM_002783593.1

1e-14

XM_002263113.1

8e-37

WD40-repeat-containing protein

CP002013.1

4e-32

Ubiquitin-like protein

EU153190.1

5e-85

GU555692.1

5e-29

Unknown

AC140319.3

5e-5

Hydroxylase

XM_002026350.1

5e-7

YP_003265741.1

3e-33

EU742862.1

1e-29

HP446650.1

1e-10

Unknown

GU554259.1

5e-18

TPR repeat-containing protein

XM_002140365.1

2e-4

Kinesin-like calmodulin binding
protein

Thioredoxin/protein disulfide
isomerase

Methyltransferase or
transcriptional regulatory protein
Adenosylhomocysteinase
Structure specific recognition
protein
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SGNH-hydrolase superfamily
EU449488.1

4e-4

β-lactamase

GQ168544.1

1e-13

Nitrate transporter protein

HM147134.1

3e-35

protein (lipase or esterase)

2.2.2.2 Screening from toxic chemicals
Another strategy used to screen the K. brevis cDNA library was to grow the E.
coli in the presence of antibacterial compounds, which can be hydrolyzed by an EH
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.

The same K. brevis cDNA library described above were plated on a M9 minimal media
plate containing 0.2% glycidyl butyrate (Figure 33). After incubating overnight, only 12
colonies grew. The 12 colonies were then streaked on to LB plates to obtain single
colonies. Plasmids were extracted through mini-prep and were sent to Eurofins Genomics
for sequencing. After tBLASTx analysis, unfortunately, no EH-related genes were found.
Table 2 showed all the sequences with an E value lower than 1e-4 to some known
sequences. Four sequences were found to have an E value lower than 1e-4 to the
sequences in NCBI database. Only one sequence was able to identify as histone-like
protein, the other three were unable to assign because they were similar either to a whole
genome or cDNA of some organisms in NCBI database.

Figure 33. Structure of antibacterial compound, glycidyl butyrate
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Table 2. Screening using glycidyl butyrate

Accession No. of most
Predicated protein

E-value
similar known sequence

Unknown

AC103411.8

6e-7

Unknown

GU555355.1

4e-7

Histone-like protein

AF482694.1

4e-31

Unknown

CU367609.1

2e-9

2.2.3 Searching Expressed Sequence Tag (EST) library
EST is a short sub-sequence of a cDNA sequence. EST libraries are usually used
to identify gene transcripts. Sequences from a K. brevis EST library consisting of 65,000
ESTs (22,000 contigs) has been published by The Marine Genomics Project
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. Data

analysis was made to search for the three types of EHs within this library.

2.2.3.1 Searching for α,β-hydrolase EH
tBLASTn analysis of the K. brevis EST library against a variety of prokaryotic
and eukaryotic EHs of the α, β-hydrolase type revealed a transcript (MGID2034061) with
significant homologies having Expect values ranging from 10-126 to 10-103. The identified
EST coded for a 393 amino acid protein with a calculated molecular weight of 44.6 kD.
BLASTp analysis of this protein against the NCBI non-redundant protein database
returned a putative EH with Expect value of 10-126, from the polar, eukaryotic microalga
Coccomyxa subellipsoidea
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as the closest match. Table 3 shows the alignment of the

translated protein with the α, β-hydrolase type EH from Aspergillus niger (NCBI
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Accession Number: CAB 49813.1

96

. The two conserved catalytic tyrosine residues can

be identified in the translated protein. However, the Asp-His-Asp catalytic triad is
replaced with Asp-His-Glu, which suggests the newly found EH was a microsomal EH
(mEH) as all known mEHs except the EH from Aspergillus niger have a glutamic acid in
their catalytic triad 96-97.
Table 3. Alignment of putative K. brevis EH with Aspergillus niger EH. Catalytic residues are
highlighted in red.
K. brevis EH
Aspergillus niger EH

----------MPLTDLKPFKLTVPDQQLDDLKYRISATRWPDQLDSPANANWEYGTEITY 50
MSAPFAKFPSSASISPNPFTVSIPDEQLDDLKTLVRLSKIAPPTYESLQADGRFGITSEW 60
. . :**.:::**:****** : :: .
.. :*: .:*
:

K. brevis EH
Aspergillus niger EH

LKSLAEYWRTTFSWRKQEELLNAMPQFTAKLNGVTVHFVHQRCLSSPTAPALLICHGWPG 110
LTTMREKWLSEFDWRPFEARLNSFPQFTTEIEGLTIHFAALFSERE-DAVPIALLHGWPG 119
*.:: * * : *.** * **::****::::*:*:**.
. . * .: : *****

K. brevis EH
Aspergillus niger EH

SIFEFHKVLGPLAEN-------FHVVAPSIPGYGFSEAP-HKRGFNAPEAARLFHALMLE 162
SFVEFYPILQLFREEYTPETLPFHLVVPSLPGYTFSSGPPLDKDFGLMDNARVVDQLMKD 179
*:.**: :* : *:
**:*.**:*** **..* .:.*. : **:.. ** :

K. brevis EH
Aspergillus niger EH

LGY-QEYVAQGGDWGSVITQCIGKLFPKQCKAIHINMPTAPRPKD-FDMSKLNPAEVEGL 220
LGFGSGYIIQGGDIGSFVGRLLGVGF-DACKAVHLNLCAMRAPPEGPSIESLSAAEKEGI 238
**: . *: **** **.: : :* * . ***:*:*: :
* : .:..*..** **:

K. brevis EH
Aspergillus niger EH

RRTMAFNTYGTGYQKISGTKPQTLSYGLNDSPIGLLAWMTEKFRDWSDCNGTLENAFTQD 280
ARMEKFMTDGLAYAMEHSTRPSTIGHVLSSSPIALLAWIGEKYLQWVDKP------LPSE 292
*
* * * .*
.*:*.*:.: *..***.****: **: :* *
:..:

K. brevis EH
Aspergillus niger EH

EILTNAMIYWVSQSIGSSMRFYYENIAVMPGTSKEMIELAAVKVSVPTAVAMFPKEIFFC 340
TILEMVSLYWLTESFPRAIHTYRETTPTASAPNGATMLQKELYIHKPFGFSFFPKDLCPV 352
** . :**:::*: ::: * *. .. ....
:
: : * ..::***::

K. brevis EH
Aspergillus niger EH

PRAWCEQAYNLQQYTRFEAGGHFAALEKPEELVKDIKDFFLRRLDLDKNQSRL 393
PRSWIATTGNLVFFRDHAEGGHFAALERPRELKTDLTAFVEQVWQK------- 398
**:*
: ** : . ********:*.** .*:. *. : :

2.2.3.2 Searching for limonene EH
tBLASTn
transcripts
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analysis of a K. brevis EST library consisting of 22,000 predicted

against Rhodococcus erythropolis LEH and nine other known or putative

LEHs which are associated with biosynthetic gene clusters of bacterial polyethers:
monenesin (MonB1 and MonB2), lasalocid (Lsd19A and Lsd19B), nanchangmycin
(NanIA and NanIB), tetronomycin (TmnB), nigericin (NigB1 and NigB3) was
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performed. All failed to return any significant homologies with the smallest Expect
values on the order of 10-5.
Even though data mining of EST library did not give any limonene EH, it still
cannot exclude the possibility of limonene EH existing in K. brevis. Since many EHs
have been identified, one possible way to search new EH from K. brevis based on the
conserved region on the known EHs. The sequences including MonB1, MonB2, Lsd19A,
Lsd19B, NanIA, NanIB, TmnB, NigB1 and NigB3 can be obtained from NCBI.
Alignment of these known limonene EHs, revealed two conserved regions, ‘EDPV’ and
‘GD(E)VD(E)’. Degenerate primers were designed based on these common residue
sequences 99. No conserved region was found near 3’ end, an oligo dT primer was used as
K. brevis is eukaryotic, with polyadenylated mature mRNA.
Table 4. Alignment of some known limonene EH involved in biosynthesis of polyether
MonBII

-MNEFARKKRALEHSRRINAGDLDAIIDLYAPDAVLEDPVGLPPVTGHDALRAHYEPLLA 59

NigB1

MIDERSRKKLILEHSRRMNAADVDGLLELYADEVTFEDPVGSGRRTGRDALRAHFEELAA 60

NanIA

MLNERTRKKIAREHSRRLSEGDIDGLLDLYAKDVTFEAPVGAGGQAGHEALRAHFESAVA 60

LSD19B

-PDEERRKELAREHCLRINDGDVDGLLKLYSPRIRFEDPVGSWTRTGLEALRAHATMAVG 59

TmnB

MLDEDARKRVALEYCRRIGAGDVDGVLALFADPLHVEDPVGDKTFTARAEYRAHIARLVS 60

LSD19A

MPAETVRKEVALEYCRRVNAGELEGVLQLFAPDALLVDPLGTEPVVGRAALAARLAPALR 60

MonBI

MPDEAARKQMAVDYAERINAGDIEGVLDLFTDDIVFEDPVGRPPMVGKDDLRRHLELAVS 60

NigBIII

MADEATLKRMALEYARRMNTGDVEAVLDLFSDDIVFEDPVGAPPLIGKDALREHIAWSIE 60

NanIB

DPDEAALRELPHNYLRLLQKGDVEGTVALFTDDIVFEDPVGGLLLRGKDALREHAFRGSE 60
*

:.

::

:

.:::. : *::

.

*:*

.

:

Total RNA was isolated from K. brevis. cDNA was obtained by using AMV
reverse transcriptase (Invitrogen), K. brevis RNA as template and oligo dT as the primer
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for the first strand cDNA synthesis followed by second strands synthesis using taq DNA
polymerase. Degenerate primers were designed to amplify EH by PCR using the double
strandes cDNA as template. PCR conditions were varied through adjusting the annealing
temperature and Mg2+ concentration. Gradient and touchdown protocols were also
attempted for PCR. Unfortunately, with different conditions of PCR, products observable
by gel electrophoresis were obtained infrequently, and all products were much smaller
than expected size (300 ~500 bp). The products were sent for sequencing and all the
products turned out to be some unknown sequences without any homology to any other
sequences.
Representatives of the limonene type of EH were not identified in either the
library search or by PCR amplification, which, while unfortunate, is consistent with
inhibition assays performed on the K. brevis CFE. The involvement of limonene EHs in
the biosynthesis of bacterial polyethers has been firmly established and it has long been
believed that the dinoflagellate derived polyether ladders share a common biogenic origin
with bacterial polyethers including the involvement of one or more EHs.

2.2.2.3 Searching for leukotriene-A4 (LTA4) hydrolase
tBLASTn analysis against Emeliania huxleii LTA4 hydrolase (NCBI Accession
number: XP_005787867) returned a single transcript having an Expect value smaller than
10-5 (3 X10-6). However, BLASTx analysis of the single transcript did not return
significant homologies to any other LTA4 hydrolase.
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2.2.3.4 Additional library searches
Subsequent to these studies, three K. brevis reference transcriptome libraries
containing 86,580 (Wilson strain), 93,668 (strain SP1) and 84,309 (strain SP3) predicted
transcripts became available

100

. tBLASTn analysis of these transcriptome libraries

against the 10 LEHs and the Emeliania huxleii LTA4 hydrolase were performed. Against
the LEHs, a single transcript from the SP1 transcriptome returned an Expect value of less
than 10-5 (4 X 10-6) against NanIB. However, BLASTx analysis against the NCBI nonredundant protein database did not return any significant homologies (10-6 or less).
Against the Emeliania huxleii LTA4 hydrolase, six transcripts from each library with
expect values ranging from 10-12 to10-141 were identified. All 18 sequences are BLASTed
against the database in NCBI, revealing the three transcripts with the lowest E value
showed very high homology with known LTA4 hydrolase. These three sequences are
from three libraries respectively and alignment results showed they are identical
sequences. The remaining sequences were suggested to be aminopeptidase, which is not
surprising because the query protein LTA4 hydrolase is a bifunctional protein, the second
function of which is aminopeptidase 101.
The cDNA sequence of the α,β-EH which was found in Marine Genomics K.
brevis EST library was used as a query for a nucleotide BLAST analysis of the three
reference transcriptomes. Each of theses transcriptome libraries returned identical
sequences (Locus 28231 from SP1; Locus 35217 from SP3; Locus 51025 from Wilson)
each having Expect values ranging from 10-79 to10-84. Additionally, a single transcript
which was identical to the previously found EH was identified in the SP3 library (SP3
Locus 73930). When the newly identified sequence (Locus 28231 from SP1) was used as
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a query to search the Marine Genomics EST library, a single 50 bp sequence was
returned which exactly matched the query. The alignment of these two α,β-EHs is shown
in Table 5.
Table 5. Alignment of two K. brevis mEHs. Catalytic residues are highlighted
K.brevis EH1

-------------------------------------------------MPLTDLKPFKL 11

K.brevis EH2

MLKIAGGICCILFVAFLSALPIIIDKLFIPTPPRSPEALLRSETEWGNEPEMSDIQPYKI 60
::*::*:*:

K.brevis EH1

TVPDQQLDDLKYRISATR-WPDQLDSPANANWEYGTEITYLKSLAEYWRTTFSWRKQEEL 70

K.brevis EH2

AYDLKHLTDLRRRLLSWRPWSDTVPMAHSKNSSYGVNPKYMQSLISYWRDTYNWRSYEQK 120
:

::* **: *: : * *.* :

. . * .**.: .*::** .*** *:.**. *:

K.brevis EH1

LNAMPQFTAKLNGVTVHFVHQRCLSSPTAPALLICHGWPGSIFEFHKVLGPLAEN---FH 127

K.brevis EH2

INSLGLKSTTIDGLRLVFHEVNGGKQ---KAILLLHGWPGSIHEFSKVLLKINASTQEYS 177
:*::

::.::*: : * . .

..

*:*: *******.** ***

:

.

:

K.brevis EH1

VVAPSIPGYGFSEAPHKRGFNAPEAARLFHALMLELGYQEYVAQGGDWGSVITQCIGKLF 187

K.brevis EH2

IVCPSLPGFGFSSAPTEEGYSSVEMALTLLRLMAKLKYRTFVVQGGDWGSVVARAMAYID 237
:*.**:**:***.** :.*:.: * *

:

** :* *: :*.********:::.:. :

K.brevis EH1

PKQCKAIHINMPTAPRPKD---FDMSKLNPAEVEG--LRRTMAFNTYG----TGYQKISG 238

K.brevis EH2

PVSVIGLHLNFFPVLPPPGTYVFDMFKVWAFDDENSKSRAKKLLDVNGLFQITGYFHQQA 297
* .

.:*:*: ..

* .

*** *: . : *.

* .

::. *

*** : ..

K.brevis EH1

TKPQTLSYGLNDSPIGLLAWMTEKFRDWSDCNGTLENAFTQDEILTNAMIYWVSQSIGSS 298

K.brevis EH2

TMPETLGFALSDSPAGLAAWILEKFQGWSDPDRPIEDKFRRDDLLTNIMLYWLTNTITSS 357
* *:**.:.*.*** ** **: ***:.*** : .:*: * :*::*** *:**::::* **

K.brevis EH1

MRFYYENIAVMPGTSKEMIELAAVKVSVPTAVAMFPKEIFFCPRAWCEQAYN-LQQYTRF 357

K.brevis EH2

MRMYKEVVSLEA------ISVLYLPVTVPVGISLFPHEVLSPPDTVIKKHFTNIVQFTKH 411
**:* * ::: .

*.:

: *:**..:::**:*::

K.brevis EH1

EAGGHFAALEKPEELVKDIKDFFLRRLDLDKNQSRL 393

K.brevis EH2

KQGGHFAALEEPKAFTDDLLAFLAKLPKSVPGTDTN 447
: ********:*: :..*:

*: :

.
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. .

* :

:: :. : *:*:.

2.2.3.5 Analysis of identified EHs
As described previously, most known EHs are α,β-fold EHs. In mammals, there
are two types of α,β-fold EHs: soluble (or cytosolic) EH (sEH) and microsomal EH
(mEH). The mEHs are believed to be involved in the metabolism of xenobiotics whereas
the sEHs are thought to be involved in the metabolism of fatty acids

69

. However, only

mammalian genomes encode both sEH and mEH whereas yeast, fungi, insects and plants
encode only one type and the role of the absent EH type may be assumed by the other.
These two types of EHs were first distinguished by their subcellular localization, but they
were found to have distinct and complementary substrate specificity. Generally, sEH
seems to prefer trans-di-, tri- and tetra- substituted epoxides, whereas mEH prefer monoand cis-di- substituted epoxides

75

. All the known mEH except that from Aspergillus

niger have the catalytic triad Asp-His-Glu, whereas most sEH have an Asp-His-Asp
instead. The mutation of glutamic acid in the rat mEH to aspartic acid increased the
enzyme activity by more than an order or magnitude 102. Mutation of aspartic acid in the
Aspergillus niger EH to glutamic acid led to an activity reduction by half
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. The

mechanisms of these two enzymes are the identical, except difference in the aspartic acid
and glutamic acid. Both of the two found EHs in K. brevis have glutamic acid rather than
aspartic acid, suggesting they are mEHs.
Besides the catalytic triad, a highly variable N-terminal domain is another way to
distinguish sEH and mEH. Both of the α,β fold type EHs identified in K. brevis belong to
the mEH class. The N-terminal domains of mEHs are characterized by a microsomal
domain which may or may not be preceded by an N-terminal membrane anchor. The
membrane anchor is found in mammalian and insect mEHs, but not in EHs from yeast,
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fungi or bacteria and is also absent in the two K. brevis mEHs. EHs may be further
categorized according to the length of two loops: the NC-loop which links the N-terminal
catalytic domain and the cap domain (the cap domain contains the two catalytic Tyr) and
the cap-loop, which links two α-helices (α6 and α7) within the cap domain. The length of
these loops may be determined from the pair wise alignment with the EH from A. niger
(also an mEH) or by inspection of a homology model constructed using the A. niger EH
crystal structure as template
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. In A. niger the NC loop is located from Leu215 to

Leu249 (35 residues) whereas the cap-loop is located from Trp284 to Ser291 (8 residues).
The lengths of the NC loops of the K. brevis EHs are 36 and 43 residues whereas both
cap-loops are 14 residues. mEHs are characterized by having long to very long NCloops (33 or more residues) and short to medium cap-loops (8-36). The K. brevis NCloops and cap-loops would be considered very long and medium in length, respectively.
The length of these domains is believed to govern the substrate selectivity of the EH and
this combination of long/med NC-loop/cap-loop would suggest selectivity for aromatic
epoxides.

2.3 MATERIAL AND METHODS
2.3.1 Material
Substrate 2 was prepared from trans-styrylacetic acid and 7-methoxy-2napthaldehyde, as previously described
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. Chemicals were purchased from Sigma-

Aldrich (St. Louis, MO). K. brevis culture (Wilson strains) were obtained from Mote
Marine Laboratory (Sarasota, Florida) and maintained in L1-Si medium, with the
exception that the NH 15 vitamin supplement
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replaced the L-1 supplement, in a

growth chamber at 20ºC. Growth was monitored by counting a 1:10 dilution of culture in
Z-pak reagent using a Beckman Z-series Coulter Counter with aperture size between
10~30 μm according to the manufacturer’s instructions. Coomassie Plus Protein Assay
Reagent for Bradford assay was purchased from Pierce (Grand Island, NY). Absorbance
and fluorescence were read on a Synergy™ 2, micro-plate reader from Bioteck
Instrument, Inc (Winooski, VT). Reagents for the glucose-6-phosphate dehydrogenase
assay were purchased from Sigma-Aldrich.
Reagents for RNA isolation were purchased from Sigma-Aldrich. 2YT agar for
growing recombinant E. coli was purchased from Becton Dickinson (Franklin Lakes, NJ).
Plasmid extraction kit (QIAprep Spin Miniprep Kit) was purhased from Qiagen
(Valencia, CA). Sequencing was performed by Eurofins Genomics (Huntsville, AL).

2.3.2 Methods
Prep of K. brevis cell free extract (CFE)
K. brevis culture (200 mL) was concentrated by centrifugation (5 min at 450 x g)
and the supernatant discarded. The cells were resuspended in phosphate buffer (800 μL,
50 mM pH 7.0) and vortexed for 1 min. This suspension was centrifuged (14,000 x g for
10 min) and the pellet was discarded. Homogenates were analyzed for protein
concentration and glucose-6-phosphate dehydrogenase activity as described below.
Typical protein concentrations ranged from (0.25 to 0.5 mg/mL).

Bradford assay
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Proteiin concentraation was deetermined byy Bradford aassay. Five cconcentratioons of
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Figure 34. Standard curve for protein aassay

Glucose-6-ph
G
hosphate deh
hydrogenase (G6PD) acttivity
A glu
ucose-6-phossphate dehyd
drogenase aassay was peerformed ass positive coontrol
prrior to the EH
E assay. K. brevis homo
ogenate (1500 µl) was miixed with asssay buffer (550 µl,
31 mM phosp
phate bufferr, 7.5 mM gllucose-6-phoophate, 2.5 m
mM NADP,, 38 mM MggCl2),
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activity of homogenate is more than twice that of boiled homogenate. Each sample was
assayed in triplicate.

1

0.837

G6DP assay
Absorbance
(450 nm)

0.8
0.6
0.4

0.194

0.2
0
CFE

Boiled CFE

Figure 35. A typical G6PD assay

EH/esterase assay
Fluorescent probe 1/2 (2 μL, 10 mM in DMSO, final concentration100 μM) was
added to K. brevis CFE (198 μL) in duplicate. Fluorescence was monitored at 330 nm
EX/ 465 nm EM (Synergy™ 2, Bioteck Instrument, Inc.) every 5 minutes at 30°C. For
each data point, n = 2; the range is within the data point. The concentration of reporter 3
was calculated from a calibration curve prepared by measuring the fluorescence of 7methoxy-2-naphthaldehyde (reporter 3) (0, 3.1, 12, 25, 50 μM in phosphate buffer (50
mM phosphate, pH 7.0). Each reporter 3 solution was assayed in duplicate; error bars are
smaller than data points.
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allcohol (24:1) and the mixture
m
was vortexed.
v
A
After centrifuugation at (14,000 x g fo
for 15
minutes)
m
at 4°C,
4
the top
p (aqueous) phase was transferred to new tubee which conntains
eq
qual volumee of ice cold EtOH. RNA
A was alloweed to precipiitate at -20 ddegrees overnnight.
The
T mixture was centrifu
uged at 4° C,
C for (30 m
minutes at 144,000 x g) annd the pellett was
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washed with cold 70% EtOH (700 µL). After air-drying, the pellet was reconstituted in
water (50 µL). Total RNA concentration was quantitated using the Nanodrop 2000
(Thermo Scientific)

PCR reactions
Degenerate primers were designed based on the conserved region mentioned
previously. Two forward primers (GTATATTGYNCARGGNGGNGAYTGG) and
(TACCNWSNHTNCCNGGNTAYGGNT) were

paired

with

oligo

dT

primer

respectively. The PCR reaction components were mixed according to the Taq DNA
polymerase manufacurer’s instructions. The concentration of each component in PCR are
as following: dNTP (200 µM), reaction buffer (1x), primers (0.05-1 µM for both forward
and reverse), template cDNA (< 1,000 ng), Taq DNA polymerase (1.25 unit/50 µL PCR).
Typical reactions were carried out by using the following steps: initial denaturation at 94
ºC for 2 minutes followed by 35 cycles of 94 ºC for 15 seconds (denaturation), 65 ºC for
30 seconds (annealing), and 68 ºC for 30 seconds (extension). Gradient annealing
temperatures (65, 63, 61, 59, 57, 55, 53, 51 ºC) were used to find optimize condition. A
touchdown reaction with annealing temperature decrease from 65 to 51 ºC in first eight
cycles was also tested.
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3. CLONING, EXPRESSION AND ANALYSIS OF EH
3.1 INTRODUCTION
As described in the previous chapter, one EH was found from the Marine
Genomics Project K. brevis EST library. It could be heterologously expressed in bacteria.
To find evidence to support the hypothesis that EH from polyether ladder producing
dinoflagellates will catalyze the construction of polyether ladder framework from
polyepoxide substrates, it is necessary to carry out a series of in vivo enzymatic reactions.
Similar behavior on proposed natural substrates and on designed substrates would
strongly support the role of EH in brevetoxin biosynthesis.
In this chapter, one EH from K. brevis was cloned, expressed and characterized
using different substrates. The potential of this EH in semi-enzyme synthesis of cyclic
ethers was evaluated using a simple substrate trans-4,5-epoxy-hexanol. The EH activity
and relative EH mRNA levels were evaluated in two strains of K. brevis in an effort to
identify a correlation between EH activity or mRNA expression with the brevetoxin
content.

3.2 RESULTS AND DISCUSSION
3.2.1 Cloning and expression of K. brevis EH
As the EH was to be expressed in E. coli, optimization of the codon usage is
necessary to improve the heterologous expression. The EH sequence found in K. brevis
EST library was sent to Genescript (Piscataway, NJ) for optimization and synthesis. The
optimized EH DNA sequence was synthesized and cloned into pUC19 by Genescript.
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Table 6 shows the native and optimized sequence, the nucleoside without the stars are
optimized for E. coli codon usage.
Table 6. Comparison of optimized (for E. coli) and native K. brevis EH sequence
optimized

ATGCCGCTGACGGATCTGAAACCGTTCAAACTGACCGTTCCGGATCAGCAGCTGGATGAT 60

native

ATGCCGTTGACTGATTTGAAACCCTTTAAGCTTACTGTGCCTGATCAGCAGCTGGATGAT 60
****** **** *** ******* ** ** ** ** ** ** ******************

optimized

CTGAAATATCGTATCTCTGCCACCCGCTGGCCGGATCAGCTGGATAGTCCGGCGAACGCC 120

native

TTAAAGTATCGCATCTCTGCCACACGCTGGCCAGACCAGCTGGATTCACCTGCTAATGCA 120
* ** ***** *********** ******** ** *********

** ** ** **

optimized

AATTGGGAATATGGCACCGAAATTACGTACCTGAAAAGCCTGGCAGAATACTGGCGTACC 180

native

AACTGGGAATATGGGACTGAAATCACTTACTTGAAAAGCTTGGCGGAATACTGGCGCACC 180
** *********** ** ***** ** *** ******** **** *********** ***

optimized

ACGTTTTCTTGGCGCAAACAGGAAGAACTGCTGAACGCAATGCCGCAGTTCACGGCGAAA 240

native

ACGTTCAGCTGGCGTAAACAAGAAGAGCTTCTCAATGCAATGCCCCAGTTTACTGCAAAG 240
*****

***** ***** ***** ** ** ** ******** ***** ** ** **

optimized

CTGAATGGCGTGACCGTTCATTTTGTTCACCAGCGTTGCCTGAGCTCTCCGACCGCACCG 300

native

CTGAACGGTGTGACAGTGCACTTTGTTCACCAGCGCTGCTTGAGCAGTCCGACAGCACCT 300
***** ** ***** ** ** ************** *** *****

****** *****

optimized

GCACTGCTGATTTGTCATGGCTGGCCGGGTAGCATCTTTGAATTCCACAAAGTGCTGGGT 360

native

GCTCTGCTGATTTGCCATGGCTGGCCAGGCTCTATCTTTGAGTTTCACAAGGTGCTGGGT 360
** *********** *********** **

******** ** ***** *********

optimized

CCGCTGGCCGAAAACTTTCATGTGGTTGCACCGAGTATTCCGGGCTATGGTTTTAGCGAA 420

native

CCTTTGGCTGAGAATTTCCATGTCGTCGCCCCATCTATTCCTGGGTATGGCTTCTCAGAG 420
**

**** ** ** ** ***** ** ** **

****** ** ***** **

**

optimized

GCGCCGCATAAACGTGGTTTCAATGCACCGGAAGCAGCACGTCTGTTTCACGCACTGATG 480

native

GCTCCACACAAGCGTGGTTTCAACGCTCCGGAAGCAGCCCGTTTGTTTCATGCACTCATG 480
** ** ** ** *********** ** *********** *** ******* ***** ***

optimized

CTGGAACTGGGTTATCAGGAATACGTTGCGCAGGGCGGTGATTGGGGCTCTGTGATTACG 540

native

CTTGAGCTTGGATATCAAGAGTACGTCGCTCAAGGAGGTGATTGGGGGTCGGTGATCACG 540
** ** ** ** ***** ** ***** ** ** ** *********** ** ***** ***

optimized

CAGTGCATCGGTAAACTGTTTCCGAAACAGTGTAAAGCAATTCACATCAACATGCCGACC 600

native

CAATGCATAGGCAAGCTGTTTCCAAAGCAGTGCAAAGCCATCCACATCAACATGCCAACG 600
** ***** ** ** ******** ** ***** ***** ** ************** **

optimized

GCACCGCGTCCGAAAGATTTCGATATGTCTAAACTGAACCCGGCAGAAGTGGAAGGTCTG 660

native

GCACCACGTCCGAAGGACTTCGACATGTCCAAGCTGAATCCAGCAGAAGTAGAAGGCCTA 660
***** ******** ** ***** ***** ** ***** ** ******** ***** **

optimized

CGTCGCACGATGGCATTTAATACCTATGGCACGGGTTACCAGAAAATCAGTGGTACCAAA 720
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native

AGGCGTACAATGGCATTCAATACTTACGGCACTGGGTACCAGAAGATTTCAGGCACCAAA 720
* ** ** ******** ***** ** ***** ** ******** **

** ******

optimized

CCGCAGACGCTGAGCTATGGCCTGAATGATTCTCCGATTGGTCTGCTGGCGTGGATGACC 780

native

CCTCAAACATTATCTTATGGATTGAATGATTCTCCCATTGGGCTATTGGCATGGATGACG 780
** ** **

*

*****

************* ***** **

**** ********

optimized

GAAAAATTCCGTGATTGGAGCGATTGCAACGGTACCCTGGAAAATGCGTTTACGCAGGAT 840

native

GAGAAGTTCCGCGATTGGAGTGATTGCAATGGCACCTTGGAGAATGCATTCACACAAGAC 840
** ** ***** ******** ******** ** *** **** ***** ** ** ** **

optimized

GAAATTCTGACCAACGCCATGATCTACTGGGTTTCTCAGAGTATTGGCAGTAGCATGCGC 900

native

GAAATACTCACAAACGCAATGATATATTGGGTCTCTCAGTCAATCGGCTCAAGCATGCGA 900
***** ** ** ***** ***** ** ***** ******

** ***

********

optimized

TTCTATTACGAAAATATCGCCGTGATGCCGGGTACGAGTAAAGAAATGATTGAACTGGCA 960

native

TTCTACTATGAAAATATTGCAGTGATGCCTGGAACAAGTAAAGAAATGATTGAACTTGCT 960
***** ** ******** ** ******** ** ** ******************** **

optimized

GCGGTGAAAGTTAGCGTGCCGACCGCCGTTGCAATGTTTCCGAAAGAAATCTTTTTCTGC 1020

native

GCTGTAAAGGTATCAGTTCCGACAGCCGTTGCGATGTTTCCCAAGGAAATATTTTTCTGT 1020
** ** ** **

** ***** ******** ******** ** ***** ********

optimized

CCGCGTGCGTGGTGTGAACAGGCCTATAACCTGCAGCAGTACACCCGCTTTGAAGCGGGC 1080

native

CCGCGAGCTTGGTGCGAACAAGCCTACAATCTGCAGCAGTATACTAGATTTGAGGCGGGT 1080
***** ** ***** ***** ***** ** *********** **

* ***** *****

optimized

GGTCATTTCGCCGCACTGGAAAAACCGGAAGAACTGGTGAAAGATATCAAAGATTTCTTT 1140

native

GGACACTTCGCAGCACTCGAGAAGCCGGAGGAACTTGTGAAGGACATCAAGGATTTCTTC 1140
** ** ***** ***** ** ** ***** ***** ***** ** ***** ********

optimized

CTGCGTCGCCTGGATCTGGATAAAAATCAGAGCCGTCTGTAA 1182

native

CTGAGGAGATTGGACTTGGACAAAAATCAAAGCAGGCTCTAG 1182
*** *

*

****

**** ******** *** * ** **

Specific primers (Forward: CACAATCATATGCCGCTGACGGA, Reverse:
AATAAGCTTTAATGATGATGATGATGATGCAGACGGCTCTGATTTTTAT) were
designed to amplify the codon optimized K. brevis EH. The primers incorporated HindIII
(reverse primer) and NdeI (forward primer) restriction sites for directional cloning and 6
histidine codons (reverse primer). Because NdeI needs at least 6 extra nucleotides at both
sides of cutting site, the amplified gene was first ligated into a TA vector, pCR2.1 to
improve digestion efficiency. The recombinant pCR2.1-KbEH was then transformed into
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E. coli competent cells and extracted using a mini-prep kit (Qiagen). After double
digestion with HindIII and NdeI, the KbEH gene and expression vector pET30a+ were
ligated to construct the final recombinant plasmid (Figure 37).

Figure 37. Recombinant pET-30a+-KbEH

The recombinant plasmid pET30a+ was transformed into E. coli strain BL21/DE3
for protein expression. After induction by IPTG, protein was then extracted and purified
by nickel affinity chromatography. Molecular mass was confirmed to be 44 kD by SDS
polyacrylamide gel electrophoresis (PAGE) comparing with protein ladder (Figure 38).
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Figure 38. SD
DS PAGE of expressed
e
EH
H after purificcation and diaalysis. Lanes M
M: Precision Plus
Protein Unstained Stan
ndards (Bio-R
Rad 161-0363 ) lane 1: lysatte; lanes 2-3: column flow
wthrough; lanes 4-5: co
olumn washess by washing bbuffer; lane 66: eluted by ellution buffer.

3.2.2 Optimizzation of pH for EH assaay
In ord
der to betterr study the characters of EH, the assay condditions shoulld be
op
ptimized. pH
H is one off the most essential facttors for enzyyme activityy. K. brevis CFE
dissolved in different pH
H phosphate buffer weree incubated with fluorescent probe. The
reesult (Figuree 39) showed that wheen pH was 7.0, the EH
H had the bbest activityy. All
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Figure 39. Opttimization of ppH for EH acctivity
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3.2.3 EH vs Esterase activity
The EH found in the Marine Genomics K. brevis EST library is an α, β-fold EH,
which belongs to α, β-fold hydrolase superfamily. Esterases, the hydrolase enzymes that
hydrolyze esters into an acid and an alcohol, also belong to this superfamily
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. In the

method we used to determine EH activity, if the enzyme is an esterase rather than EH, the
fluorescent report will also be produced, as shown in Figure 27.
In order to confirm the enzyme obtained is EH rather than esterase, the precursor
of the fluorescent probe without the epoxide group was used as the substrate in the assay.
The expressed protein showed no activity with the alkene demonstrating that the enzyme
was EH.

Fluoresence reporter 3
concentration (uM)

EH vs esterase essay in K. brevis EH
14

KbEH + 1

12

Kb EH + 2

10
8
6
4
2
0
0

100
200
Time (min)

300

Figure 40. EH vs esterase activity in K. brevis EH

3.2.4 Optimization of fluorescent substrate
It was reasoned that a substrate containing aliphatic rather than aromatic
substituents would be more representative of the native substrate if it were involved in
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brrevetoxin biiosynthesis. Thus a seccond probe 2b was preppared from trans-3-hexenoic
accid accordin
ng to the proccedure descrribed by Jon es for the syynthesis of 2 90.
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Figurre 42. EH acttivity using tw
wo different ssubstrates

3.2.5 Charactterization of K. brevis EH
H
Substrrate and en
nantioselectiv
vity of the K. brevis E
EH was asssessed by kiinetic
sttudies. Kineetic parameters of the enzyme
e
usinng substrates 2 and 2b were perfoormed
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using the sensitive fluorescent assay with different substrate concentration (100 µM,
75µM, 50µM and 25µM). Other substrates having no fluorescent reporter group were
evaluated by GC-MS analysis of the reaction mixtures using 1-naphthol as an internal
standard. A standard curve was obtained by using different substrate/internal standard
ratio (10:1, 8:1, 6:1, 4:1, 2:1, 1:1, 1:2, 1:4, 1:6, 1:8, 1:10). Figure 43 shows the molar

Area ratio (Substrate/IS)

ratio vs GC-MS response ratio of styrene oxide and internal standard.
Molar ratio/GC-MS response ratio of
styrene oxide
3
y = 0.268x - 0.0737
R² = 0.9799

2
1
0
0

5

Molar Ratio (Substrate/IS)

10

Figure 43. Molar ratio/GC-MS response ratio of styrene oxide

Enantiomers of styrene oxide and 1-butane oxide were used to evaluate the
enantioselectivity of the enzyme. Figure 44 shows the substrates used in kinetic studies.
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Figure 44. Epoxide substrates used in kinetic studies.

The data shown in Table 7 indicates that aliphatic substitutents are preferred over
aromatic substituents by approximately 5:1 and the enzyme shows only a slight
preference for R over S enantiomers.

Table 7. Kinetic parameters of the K. brevis EH with various substrates

Substrate
Probe 2 (R = Ph)
Probe 2b (R = Et)
(R) styrene oxide
(S) styrene oxide
Racemic styrene oxide
α-methylstyrene oxide
(R) 1-butane oxide
Racemic 1-butane oxide
1,2,7,8-diepoxyoctane

KM (μM)
13.6
161
6240
6430
6570
5310
25,800
22,200
4800

kcat (sec-1)
7.81E-4
4.46E-3
9.01E-1
8.32E-1
8.58E-1
3.31E-1
6.15
5.36
7.12

kcat (sec-1)/Km (M)
57.4
27.7
144
129
131
62.3
238
241
1480

With the exception of the fluorescent probes 2 and 2b, all the substrates above are
terminal epoxides. Other substrates with substituentes on both ends of epoxide were
synthesized from the corresponding alkene by epoxidation with dimethyldioxirane
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(DMDO)
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and tested, but the reaction rates were too slow to be determined using the

GC-MS method. However, disubstituted epoxides proved to be competitive inhibitors of
the K. brevis EH. Fluorescent probe 2b was used as substrate (100 μM), along with
different concentrations of these non-terminal epoxides as inhibitors. IC50 data was
obtained for the aromatic inhibitors. No inhibition was observed when using cis-2,3epoxybutane and 2,3-dimethyl-2,3-epoxybutane as inhibitors. Data in table 8 showed cisβ-methylstyrene oxide has the lowest IC50, which indicated it was the most preferred
substrate among these substrates. This is consistent with the previous reports that
microsomal EH prefer cis- over trans- substituted epoxides 75.

Figure 45. Non-terminal epoxides
Table 8. IC50 for non-terminal epoxides using fluorescent probe 2b as substrate

Substrate
cis-β-methylstyrene oxide

IC50 (mM)
3.05

trans-β-methylstyrene oxide

14.28

β-dimethylstyrene oxide

6.99
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cis-2,3-epoxybutane
2,3-dimethyl-2,3-epoxybutane

-

3.2.6 Assesment of EH catalysis of a cyclization reaction
A noteworthy distinction between the monensin pathway and the proposed
brevetoxin pathway is the site of nucleophilic attack on the epoxide substrate (Figure 45).
In the case of non-ladder polyethers, the majority of epoxide ring opening reactions
proceed via attack at the proximal carbon (exo-tet cyclization) while polyether ladder
formation requires attack at the distal carbon (endo-tet cyclization). Both the empirical
Baldwin’s rules 44 and molecular orbital calculations indicate that the endo-tet cyclization
pathway is kinetically disfavored. The exception among the bacterial polyketides is
lasalocid. In this polyether, the pyran ring arises from the endo-tet cyclization of an
intermediate epoxide. This reaction is catalyzed by the EH Lsd19. Lsd19 is a bifunctional
enzyme consisting of two domains (A and B). Each domain is responsible for the
cyclization of one of the rings. Lsd19B catalyzes the endo-tet cyclization (Figure 14 in
chapter 1).
The ability of the K. brevis EH to perform cyclization was also evaluated. As the
natural substrate analog of K. brevis are highly challenging to synthesize, the substrate
trans-4,5-epoxy-hexanol 7 was prepared as previously described
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. This substrate may

undergo endo-tet cyclization to produce pyran 8, or exo-tet cyclization to produce furan
9, or simple epoxide hydrolysis to produce the triol 10. The substrate was incubated with
the expressed EH in reaction buffer and the reaction was monitored by GC-MS. All three
possible products were identified by GC-MS
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105

, by comparison with authentic samples

however, neither the percent conversion nor the product ratio differed from that of the
buffer alone.

Figure 46. Alternate cyclization reactions or hydrolysis

3.2.7 EH activity/expression and toxin content over the life of a culture
Two cultures of K. brevis whose toxin content differs by ten-fold were evaluated
over a period of three weeks for EH activity and EH mRNA levels. Both cultures are of
the Wilson strain. However, toxin production of one culture suddenly dropped for reasons
which are not yet understood. We are unaware of any studies which have uncovered any
metabolic differences between these two cultures until now.
EH activity was assessed using the EH/esterase probe set 1b/2b (ethyl probes).
Esterase activity, determined using probe 1b, was subtracted from total activity. Cultures
were diluted on day 0 to equal cell counts (~20,000 per mL) and monitored over a 21 day
period. As shown in figure 47, 48, EH activity for the high toxin culture was consistently
higher than that of the low toxin culture. On average, EH activity for the high toxin
culture was 18% and 60% higher than the low-toxin culture when normalized to protein
content or to cell counts, respectively. Over the three weeks that the cultures were
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monitored, both showed a slight drop in EH activity when normalized to protein content
and an increase in activity when normalized to cell counts.

rate(umol/g*min)

EH activity of two strains of K.
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toxic

0.23

Average EH
activity

low toxic

0.21
0.19
0.17
0.15
5

10

15
Time (days)

20

toxic

low toxic

rate (pM/min*thousand cells

Figure 47. Left: EH activity of two strains of K. brevis over a 21 day period; right: average EH
activity of two strains of K. brevis over 21 day period (normalized to protein concentration)
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Figure 48. EH activity of two strains of K. brevis over a 21 day period; right: average EH activity
of two strains of K. brevis over 21 day period (normalized to thousand cells)

Expression of the EH mRNA was also monitored over the same period by QPCR. Figure 49 shows the ratio of cycle thresholds (Ct) for the EH mRNA normalized to
RuBisCO mRNA. As higher Ct results from less mRNA, EH mRNA levels of the low
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toxin culture were either lower (Ct higher) or equal to that of the high toxin culture when
normalized to RuBisCO. On average over the life of the culture, EH mRNA amount in
two strains has a significant difference, even though gene expression in dinoflagellates is
believed to occur principally at the translational level 106.
Average ratio
of Ct for
EH/RuBisCO

Ratio of Ct for EH/RuBisCO
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Figure 49. Left: Ratio of Ct for EH/RuBisCO for low and high toxin K. brevis; right: Average
ratio of Ct for EH/RuBisCO

3.3 CONCLUSIONS
The EH identified from K. brevis EST library was cloned and expressed in E. coli.
SDS-PAGE showed the EH was the anticipated size of 44 kD. The enzyme was
confirmed to be an EH rather than esterase by comparing activity with two fluorescent
probes 1 and 2. No activity was observed with the esterase probe 1.
As natural substrates of K. brevis EH would be very challenging to synthesize,
other simple substrates were used to obtain indirect evidence of EH involvement of
brevetoxin biosynthesis. The selectivity of the expressed K. brevis EH for aliphatic
epoxides coupled with the consistently higher level of EH activity in the high toxin vs
low toxin cultures of K. brevis is intriguing and may implicate the involvement of the EH
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in brevetoxin biosynthesis. However, the expressed EH did not appear to be capable of
catalyzing the cyclization of epoxy alcohol 7 to either a furan or pyran. However, epoxy
alcohol 7 may not sufficiently resemble the native substrate. Lsd19 was also not capable
of catalyzing the cyclization of monoepoxy alcohol which was significantly smaller than
pre-lasalocid.
The K. brevis EH showed a preference for terminal epoxides over non-terminal
epoxides. Inhibition studies using fluorescent probes as substrate, and other epoxides as
competitive inhibitors revealed preference for cis- over trans- substituted internal
epoxides. Even with terminal epoxides, the kcat was lower than those observed for soluble
EHs. All these are consistent with microsomal EH characters.
The K. brevis EH showed only slight enantioselectivity on R over S enatiomer
with a ratio of 1.08 for R/S styrene oxide and 1.15 for R/S 1-butane oxide. It has further
been suggested that an epoxidase could catalyze both the epoxidation and cyclization for
PE ladder formation without the need for EH involvement. Therefore, further studies on
epoxidase in K. brevis would possible reveal what is responsible for the enatioselectivity
in ladder polyether compound biosynthesis.

3.4 MATERIAL AND METHODS
3.4.1 Material
Gene expression vector pET-30a+ and expression E. coli strain BL21/de3 were
kindly provided by Dr. Leng (FIU). Restriction Enzymes NdeI and HindIII were
purchased from New England Biolabs (Beverly, MA). High fidelity DNA polymerase
Pfx50 kit and TOPO TA cloning kit were purchased from Invitrogen (Grand Island, NY).
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Primers were designed using the Primer-BLAST on NCBI and synthesized by Invitrogen
(Grand Island, NY). QIAprep Spin Miniprep Kit, Qiaquick gel extraction kit and Ni-NTA
agarose were purchased from Qiagen (Germantown, MD). Bacterial Protein Extraction
reagent (B-PER) was purchased from Thermo Scientific. Unstained Protein Ladders were
purchased from Bio-Rad. PCR reactions were performed on a Eppendorf Mastercycler
Gradient thermal cycler. Optical density (OD600) was measured with a micro-plate reader
(Synergy™ 2 from Bioteck Instruments, Inc.) Protein expression induction reagent
isopropyl-β-D-thiogalactoside (IPTG) was purchased from Sigma-Aldrich. LB agar and
LB broth were purchased from Becton Dickinson (Franklin Lakes, NJ). The substrates of
EH, such as styrene oxide, 1-butane oxide or their corresponding precursor alkene, such
as trans-methylstyrene, cis-methylstyrene were purchased from Sigma-Aldrich. iQ SYBR
Green Supermix was purchased from Bio-Rad (Hercules, CA). Q-PCR reactions were
performed using a DNA Engine from MJ Research (now Bio-Rad).

3.4.2 Methods
Amplification of EH gene
Pfx50 DNA polymerase, which offers 50 times better fidelity than Taq DNA
polymerase, was used to amplify the target gene. The PCR reaction components were
mixed according to the pfx50 DNA polymerase manufacurer’s instructions. The
concentration of each component in PCR are as following: dNTP (200 µM), reaction
buffer (1x), primers (0.05-1 µM for both forward and reverse), template DNA ( <1,000
ng) taq DNA polymerase (1.25 unit/50 µL PCR). The reactions were carried out by using
the following steps: initial denaturation at 94 ºC for 2 minutes followed by 35 cycles of
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94 ºC for 15 seconds (denaturation), 65 ºC for 30 seconds (annealing), and 68 ºC for 30
seconds (extension).

Ligation of PCR products and TA vector
The PCR products were treated with 2 units of Taq DNA polymerase for 30
minutes to add an “A” at both 5 and 3’ ends. The PCR products were then purified by
running an agarose gel and the band of the anticipated size was extracted from the gel
using Qiagen Gel Extration kit. The ligation was performed using Invitrogen TOPO TA
cloning kit by following the manufacture’s instructions. The recombinant plasmid was
transformed into Invitrogen’s Mach1™ competent E. coli cells provided with the cloning
kit. After incubating and shaking in SOC medium at 37 ºC (250 rpm for 1 hour), 50 μL
transformed E. coli cells were spread on LB agar with ampicillin (50 µg/mL) and X-gal
(40 µg/mL) and incubated at 37 ºC overnight. White colonies were picked and grown in
LB broth (5 mL) with ampicillin (50 µg/mL). Plasmids were extracted using QIAprep
Spin Miniprep Kit (Qiagen) according to the manufacturer’s instructions.

Recombination of EH gene with pET-30a+
The pCR TOPO plasmid containing the EH gene insert and expression vector
pET-30a+ were digested by NdeI and HindIII at 37 ºC for 4 hours. The EH gene (1.2 kb)
with cohesive ends was separated through agarose gel electrophoresis and extracted using
the Gel Extration kit (Qiagen). Doubly enzyme-digested EH gene was ligated to the NdeI
and HindIII restriction sites of the expression vector pET-30a+ using T4 DNA ligase
(Invitrogen) according to the manufacturer’s instructions.
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The newly constructed plasmid was transformed into the expression strain
BL21(DE3) by electroporation. Transformed cells were spread on LB agar plates
supplemented with kanamycin (50 µg/mL). These were then cultivated at 37 ºC
overnight. Twenty colonies were picked randomly and grown in LB broth with
kanamycin (50 µg/mL). Plasmids were extracted using QIAprep Spin Miniprep Kit
(Qiagen) according to the manufactuer’s instructions. Clones of the E. coli BL21(DE3)
containing recombinant plasmid (6.6 kb) were selected by comparing the size of plasmids
through agarose gel electrophoresis. The recombinant plasmids were sent to Eurofins
Genomics for sequencing using T7 primer and T7 terminator primer, to insure the fidelity
of the insert sequence. Glycerol stock were prepared by adding 15% sterilized glycerol
and stored at -80 ºC until use.

Protein Expression and purification
The E. coli BL21/DE3 with recombinant pet30a+-KbEH was inoculated into LB
broth with kanamycin (50 µg/mL) and shaken at 37 ºC (250 rpm) overnight. The
overnight culture (5 mL) was diluted into fresh LB broth (500 mL) with kanamycin (50
µg/mL), shaken at 37 ºC (250 rpm for 2 ~3 hour). IPTG (1mM final concentration) was
added when the OD600 reached to 0.6 ~0.8. After shaking another 4~6 hour, the culture
was centrifuged (5000 x g for 10 min). Lysozyme (2 μL, 50 mg/mL) and DNAse I (2 μl,
2500 unit/mL) as well as Bacterial Protein Extraction reagent (B-PER, Thermo Scientific,
4mL/ gram of cells) were added to resuspend the pellets. After incubation at room
temperature for 10 min, the lysate was centrifuged (15000 x g for 5 min) to separate
insoluble proteins. The supernatant was loaded on to a column of 1 mL Ni-NTA agarose
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(Qiagen), which was pretreated with 10 mL phosphate buffer (20 mM phosphate, 0.5 M
NaCl, 5 mM imidazole, 10% glycerol, pH 7.9). The column was washed by washing
buffer (20 mM phosphate, 0.5 M NaCl, 20 mM imidazole, 10% glycerol, pH 7.9) until no
more protein was eluted (as determined by A280) in the wash (typically 10 mL). This was
followed by elution buffer (20 mM phosphate, 0.5 M NaCl, 250 mM imidazole, 10%
glycerol, pH 7.9) until no more protein was eluted also as determined by A280. The
purified EH was dialyzed (MW cutoff 12-14 kD) in phosphate buffer (50 mM sodium
phosphate, pH 7.0) at 0° to 4°C, overnight, flash frozen in liquid nitrogen and stored at 80 ºC until use.

SDS-PAGE
Protein samples were mixed at 4:1 volume ratio with 5x loading buffer (10% w/v
SDS, 10 mM β-mercapto-ethanol, 20% v/v glycerol, 0.2 M Tris-HCl, pH6.8, 0.05% w/v
bromophenol blue), boiled for 5 min. The mixed protein samples and loading buffer (10
μl) were separated by SDS-PAGE with stacking gel (1.25 mL 0.5 M Tris-HCl, pH 6.8,
0.025 mL 20% (w/v) SDS, 0.67 mL acrylamide/bis-acrylamide (30%/0.8% w/v), 0.025
mL 10% (w/v) ammonium persulfate (APS), 0.005 mL TEMED, 3.075 mL H2O) and
separating gel (7.5 mL 1.5 M Tris-HCl, pH 8.8, 0.15 mL 20% (w/v) SDS, 15 mL
acrylamide/bis-acrylamide (30%/0.8% w/v), 0.15 mL 10% (w/v) ammonium persulfate
(APS), 0.02 mL TEMED, 7.2 mL H2O).

Probe synthesis
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The fluorescent probe 2 was prepared as previously described 90. A second probe
2b was prepared in a procedure identical to that of 2 except that (E)-4-phenylbut-3-enoic
acid was replaced with (E)-pent-2-enoic acid. Both alkene and epoxide were purified by
radial chromatography on a chromatotron (Harrison Research Corp.) using plates coated
with silica gel 60 PF254 containing gypsum, using 5:1 hexane/ethyl acetate.
Spectroscopic data for probe 2 were consistent with literature data 90. 1H-NMR and 13CNMR data were acquired on a Bruker Avance spectrophotometer (400 MHz for proton).
1

H NMR spectra were referenced internally to the residual proton resonance in CDCl3 (δ

= 7.26 ppm), or with tetramethylsilane (TMS, δ = 0.00 ppm) as the internal standard.
Chemical shifts are reported as parts per million (ppm) in the δ scale downfield from
TMS.

13

C NMR spectra were recorded with continuous proton decoupling. Chemical

shifts are reported in ppm from TMS with the solvent as the internal reference (CDCl3, δ
= 77.0 ppm). Accurate mass spectra were acquired using a Bruker Daltonics – ultrOTOFQ, +ESI-Q-q-TOF.

Alkene probe 1b (65%, colorless oil): 1H-NMR (CDCl3, 400 MHz): δ 7.94 (s, 1H), 7.80
(t, 2H, J = 8.4 Hz), 7.53 (m, 1H), 7.15-7.23 (m, 2H), 6.57 (s, 1H), 5.47-5.66 (m, 2H),
3.94 (s, 3H), 3.13 (m, 2H), 2.05 (m, 2H), 0.98 (t, 3H, J = 7.6Hz). 13C-NMR (CDCl3, 100
MHz): δ 170.5, 159.1, 137.8, 135.5, 130.0, 128.4, 128.3, 128.0, 126.8, 125.1, 123.8,
120.1, 119.1, 116.42, 105.9. HRMS (+ESI): calculated for C19H19NO3 [M+Na]+
332.1257, found 332.1250.
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Epoxide probe 2b (11%, yield yellow oil): 1H-NMR (CDCl3, 400 MHz): δ 8.26 (s, 1H),
7.80 (t, 2H, J = 8.8Hz), 7.52 (m, 1H), 7.15-7.26 (m, 2H), 6.60 (s, 1H), 3.94 (s, 3H), 3.08
(m, 1H), 2.75 (m, 1H), 2.66 (m, 2H), 1.59 (m, 2H), 0.97 (t, 3H, J = 5.6 Hz).

13

C-NMR

(CDCl3, 100 MHz): δ 168.8, 159.0, 135.4, 129.9, 128.2, 128.0, 127.8, 126.3, 125.0,
120.0, 116.0, 105.8, 63.4, 59.5, 55.4, 52.9, 37.3, 24.7, 9.6. HRMS (+ESI): calculated for
C19H19NO4 [M+Na]+ 348.1167, found 348.1206.

Synthesis of trans-4,5-epoxy-hexanol 7, 2-methyltetrahydro-2H-pyran-3-ol (8) and 1(tetrahydrofuran-2-yl)ethanol (9) were performed as previously described

105

. Trans-4-

hexen-1-ol (500 μL, 5.88 mmol) was mixed with NaHCO3 (1.775 g), acetone (5.6 mL)
and ethyl acetate (20 ml). Oxone (2.6 g, 17.1 mmol) was dissolved in water (18 mL) and
added dropwise to the trans-4-hexen-1-ol solution over a period of 40 min. The reaction
was stirred for another hour. The organic solvents were evaporated in vacuo. The residue
was extracted with ethyl acetate (20 mL). The organic layer was washed twice with an
equal volume of brine, dried over anhydrous Na2SO4, filtered and the solvent evaporated
in vacuo to yield trans-4,5-epoxy-hexanol 7 which was used in the next step without
further purification. Spectroscopic data for 7 were consistent with literature data. Trans4,5-epoxy-hexanol 7 was treated with a solution boron trifluoride etherate in diethyl ether
as described previously to produce a mixture of 8 and 9. Analysis by GC-MS showed
two products with the same m/z (116) in a ratio of 1:5 which were assigned as 8 and 9
respectively, based on previous reports 105.
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Synthesis of cis-β-methylstyrene oxide, trans-β-methylstyrene oxide, β-dimethylstyrene
oxide and α-methylstyrene oxide were performed using the corresponding alkene
precursors. The alkene (500 μL) was mixed with NaHCO3 (1.775 g), acetone (5.6 mL)
and diethyl ether (20 mL). Oxone (2.6 g, 17.1 mmol) was dissolved in water (18 mL) and
added dropwise to the trans-4-hexen-1-ol solution over a period of 40 min. The reaction
was stirred for another 3 hours to overnight. The organic solvents were evaporated in
vacuum at 30 oC. The residue was extracted with ethyl ether (20 mL). The organic layer
was washed twice with an equal volume of brine, dried over anhydrous Na2SO4, filtered
and the solvent evaporated in vacuo to yield the epoxide. As some of the synthesized
epoxides are low boiling, of extended exposure to vacuum often resulted lower yields.
The structures of the epoxide products were confirmed by 1H-NMR (CDCl3, 400 MHz),
which were consistent with literature data.

EH/esterase assay (fluorescent)
Fluorescent probe 1/1b, 2/2b (2 μL, 10 mM, final concentration100 μM) was
added to K. brevis homogenate (198 μL) or purified EH (198 μL) in duplicate.
Fluorescence was monitored at 330 nm EX/ 465 nm EM (Synergy™ 2, Bioteck
Instrument, Inc.) every 5 minutes at 30°C. The concentration of reporter 3 was calculated
from a calibration curve prepared by measuring the fluorescence of 7-methoxy-2naphthaldehyde (0, 3.1, 12, 25, 50 μM in phosphate buffer (50 mM phosphate, pH 7.0).
Fluorescence readings were normalized to protein concentration or cell number.
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EH assay (GC-MS)
Substrate (4 mM to 10 mM final concentrations), internal standard, 1-naphthol
(concentrations ranging from 0.4 to 4 mM; the concentration was optimized for each
substrate to a relative response ratio of 1:5 ~5:1 for substrate/internal standard in the GCMS), and purified EH (~0.1 mg) was combined in phosphate buffer (50 mM phosphate,
pH 7.0). Aliquots were removed every 5 minute and extracted using an equal volume of
dichloromethane.

Samples

were

evaporated

to

dryness

and

reconstituted

in

dichloromethane to ~20 ppm. Samples were analyzed by GC-MS (Hewlett Packard 6890
with Alltech 30 m, DB5, capillary column, 0.25 mm (ID) 0.25 μm initial temperature 80
°C for 1 minute/increase to 300 °C at 10 °C/ minute/hold for 7 minutes) and compared to
standard curve of either the diol product or starting epoxide with the internal standard.
Each reaction was performed in duplicate.

EH assay (cyclization reaction)
Trans-4,5-epoxy-hexanol 9 ( 1 μL 0.4 M stock solution in DMSO diluted to a
final concentration of 4 mM) was incubated with protein (100 μL 0.1 mg/mL in dialysis
buffer) or dialysis buffer (100 μL) alone at 30°C for 1 to 3 h. The reaction was extracted
using an equal volume of dichloromethane. The organic extracts were evaporated to
dryness and reconstituted in dichloromethane to ~20 ppm and analyzed by GC-MS as
previously described.
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Determination of KM and kcat
Specific enzyme activity was determined by the fluorescence assay (5a and 5b) or
by GC-MS for non-fluorescent products. A constant enzyme concentration of the EH
(100 μL, 0.1mg/mL, ~1.926 μM) was incubated with a range of substrate concentrations.
For fluorescent probes (2, 2b), the final concentrations of substrate were 0, 25, 50, 75 and
100 μM. For other substrates, the final concentrations of substrate were 4, 6, 8, and 10
mM. The assays were performed as previous described. Lineweaver-Burk plots were
obtained using initial velocities of substrate and their corresponding concentration, and
Km, Vmax and Vmax/Km were determined from the generated equation. These
experiments were performed in duplicate.

Inhibition assays
IC50 values could be obtained by either using fixed substrate concentration with
different concentration of inhibitors or several different substrate concentrations with a
fixed inhibitor concentration. IC50 were determined using fluorescent substrate 2b
(100uM). EH (0.1 mg/mL) was incubated with inhibitors for 2 min in phosphate buffer
(50mM, pH 7.0) at 30 °C prior to addition of the substrate. EH activity was measure as
previously described by monitoring the fluorescence. Assays were performed by
duplicate. By definition, IC50 value is concentration of inhibitor that reduces EH activity
by 50%. Six concentrations of inhibitors (0, 2, 4, 8, 12, 16 mM) were assayed to obtain
an inhibition curve of inhibition/inhibitor concentration.
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RNA isolation
K. brevis culture (100 mL) was centrifuged (450 x g for 5 min) at 20° C. The
pellet was resuspended in water (100 µL). Denaturing solution (600 µL, 5 M guanidium
thiocyanate, 50 mM Tris pH 8, 25 mM sodium citrate, 0.5% w/v Sarkosyl, 2% PEG, 0.1
M DTT) was added. After standing at room temperature for 10 minutes, NaOAc (60 µL,
3 M, pH 5.2) was added and the mixture was vortexed. An equal volume of phenol:
chloroform: isoamyl alcohol (125:24:1, pH 4.3), was added and the mixture centrifuged
at (14,000 x g for 15 minutes) at 4°C. The top (aqueous) phase was transferred to a new
tube followed by the addition of equal volume chloroform: isoamyl alcohol (24:1) and
the mixture was vortexed. After centrifugation at (14,000 x g for 15 minutes) at 4°C, the
top (aqueous) phase was transferred to new tube which contains equal volume of ice cold
EtOH. RNA was allowed to precipitate at -20 degrees overnight. The mixture was
centrifuged at 4° C, for (30 minutes at 14,000 x g) and the pellet was washed with cold
70% EtOH (700 µl). After air-drying, the pellet was reconstituted in water (50 µL). Total
RNA concentration was quantitated using the Nanodrop 2000 (Thermo Scientific).

RT-PCR
Using the isolated RNA (~1µg) as template and oligo dT as primer (1 μL, 50
mM), cDNA was synthesized using the AMV First Strand cDNA Synthesis kit (Life
Technologies) according to the manufacturer’s instructions. Reverse transcriptase
reactions were diluted 1:5 in water. PCR reactions were carried out using the newly
synthesized cDNA (1 μL of the diluted reverse transcriptase reaction), PCR mix (25 μL,
iQ SYBR Green Supermix, Bio-Rad), 1 μL of each primer (50 mM). EH primer set:

81

forward; CAAGGTGCTGGGTCCTTTGG. Reverse; TTCCGGAGCGTTGAAACCAC.
RuBisCO

primers

set:

forward;

GCAGCCTTTTATGCGGTATCG.

Reverse;

CACCAGCCATTCGCATCCATTT. PCR reactions were monitored using the DNA
Engine Opticon (MJ Research) which can detect Sybr green (excitation: 497 nm,
emission: 520 nm) fluorescence. Cycling conditions: 94 °C denaturation for 1 min,
annealing for 45 sec at 60°C, extension 72°C (RuBisCO primer set only, no extension
time for EH primers), repeat 40 cycles. The efficiency of the PCR mix was determined by
titrating the template cDNA concentrations by dilution of the RT reactions (1:5, 1:25 and
1:125) in water. Efficiencies were calculated to be ~90 to 95%.
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4. FUTURE DIRECTION
In the previous chapter, one EH identified from a K. brevis EST library was
cloned and expressed. Through the enzymatic reactions with different substrates, and by
EH activity monitoring over life time of the culture oftwo K. brevis strains, some
evidence was obtained to support the proposed biosynthetic pathway of ladder polyether
compounds. However, no direct evidence revealed the involvement of an EH in the
biosynthesis of brevetoxins due to lack of natural-similar substrates. For the same reason,
the potential of EH in semi-enzymatic synthesis to carry out kinetically disfavored
cyclization was not developed. In this chapter, some thoughts about further study of the
role of EH in biosynthesis of ladder polyethers will be discussed.

4.1 SYNTHESIZE OF MORE APPROPRIATE ENZYME SUBSTRATES
The study of Lsd19, the EH responsible for lasalocid cyclizations, revealed that
the substrates’ similarity to natural substrates significantly effected enzyme efficiency 107.
As mentioned in chapter 3, Lsd19 did show any activity towards the most simple
monoepoxy alcohol. The cyclization ability of monensin EHs was also evaluated using
several substrates. The substrates with different length of aliphatic chains (Figure 50)
were tested. Under the same conditions, the conversion of epoxide to cyclization products
was 0%, 12%, 13%, and 30% when using C2, C6, C7 and C10 analogs 88. Apparently, the
C10 analog was most similar to the proposed natural substrates of monensin EH.
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Figure 50. Substrates analog studied in monensin EHs

Therefore, in order to achieve successful cyclization reactions for K. brevis EH, it
is essential to obtain a natural substrate analog. As the complicity of brevetoxins, even
the smaller product brevenal, it is of great challenge to synthesize natural substrates of K.
brevis EH. Fortunately, the structure elucidation of brevisamide

108

, suggested the K.

brevis EH may also act on some less complex substrates.

Figure 51. Structure of brevismide

Nerolidol is a potential precursor for synthesizing K. brevis EH substrates. Both
cis and trans nerolidol could be purchased from Sigma-Aldrich. Figure 52 shows a
scheme to synthesize the substrates of EH. The product of moneepoxide (Figure 52, left)
is analog of brevisamide, whereas the product of bisepoxide (Figure 52, right) contains
the first two rings of brevenal.

84

Figure 52. Scheme for syntheizing K. brevis EH substrates using nerolidol

4.2 CHARACTERIZE THE OTHER α,β-FOLD EH
Three K. brevis reference transcriptome libraries containing 86,580 (Wilson
strain), 93,668 (strain SP1) and 84,309 (strain SP3) predicted transcripts

100

became

available. As discussed in chapter, another α, β-fold EH was identified from these three
libraries. Further sequence analysis revealed that it was also microsomal EH. As previous
reported, many organism had more than one EHs that were involved in the biosynthesis
of polyethers, such as MonBI, MonBII in monensin biosynthesis and Lsd19A, Lsd19B in
lasalocid biosynthesis. Suppose the hypothesis of biosynthesis of brevetoxins is true, it is
not known that how many EHs are involved in it. Therefore, it is worthy to characterize
the other EH found in K. brevis EST library.

4.3 CONTINUE TO SEARCH FOR LIMONENE EH
By comparing of mechanisms of α, β-fold EH and LEH, the one-step direct
hydrolysis performed by LEH is more likely involved in polyether cascade cyclization 89a.
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In fact, as to now, all EHs confirmed to be involved in the biosynthesis of polyethers are
LEHs.
In previous chapter, different methods were discussed to search for LEH.
However,no sequences similar to LEH were identified. After another three K. brevis EST
libraries were published
NanIA,

89a

, using the known LEHs, MonB1, MonB2, Lsd19A, Lsd19B,

NanIB, TmnB, NigB1 and NigB3, which were identified from polyether

biosynthetic gene clusters as query, searches were made on the new libraries. However,
still no LEH was found.
The fact that all the query sequences were from bacteria may be the reason for the
failure to find LEH in the eukaryote K. brevis. However, no LEHs in eukaryotes were
reported to be involved in the biosynthesis of polyether. BLASTp analysis of those
known LEHs revealed that these enzymes belong to NTF2-like (Nuclear transport factor)
superfamily, which includes members of the NTF2 family, Δ-5-3-ketosteroid isomerases,
scytalone dehydratases, and the beta subunit of ring hydroxylating dioxygenases. In the
sequences, a SnoaL domain, which belongs to the family of small polyketide cyclases
was detected. SnoaL was recognized as polyketide cyclase and was found in the
biosynthesis of nogalamycin

109

and was responsible for the cyclization of last ring

(Figure 53).
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Figure 53. Biosynthesis of nagalamycin

The BLASTp results drive us using other polyketide cyclase from other
organisms rather than bacteria as query to search for LEH. One hundred and seventythree polyketide cyclase from green plant were available in NCBI protein database. Of
those one hundred and seventy-three, eight were from green algae. Using all polyketide
cyclase sequences from green algae and another five sequences randomly chosen from
green plants as query, searches on all available K. brevis EST libraries were made.
Nothing was found from Marine Genomics K. brevis EST library, however, all three
transcriptome libraries contained one sequence with an E-value at 1.0e-5 with the
polyketide cyclase (Accession: CEG01925.1) from Ostreococcus tauri. BLASTp analysis
of this sequence against NCBI protein database revealed an NTF2-like domain, as other
known LEH, and a HAD-like (haloacid dehalogenase) domain.
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